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INTRODUCTION
T.he first world war gave impetus to the search
for an effective blood substitute, which could be
used in the treatment of traumatic shock, hemorrhage,
and burns.

The present world war has emphasized the

necessity of having immediately available such a
therapeutic agent.

Under conditions of National

Emergency it becomes imperative that every physician,
whether actually in the armed forces, or serving as
a civilian in the Procurement and Assignment Service,
aquaint himself with the recent therapeutic advances
in blood substitutes.

It is with this thought in

mind that I chose the subject, "Blood Plasma, and its
Role in Modern Medicine" .

This subject is so rel-

atively new and its ramifications so numerous that
only by a rather intensive review of the current
literature can one hope to gain a working knowledge .
It will be the endeavor of the essayist to present in this thesis, the history of blood plasma transfusions, a discussion of the physical, chemical and
physiological considerations, the advantages of blood
plasma over whole blood transfusions, the question of
serum versus plasma transfusion, the processing of
blood plasma, the therapeutic indications for blood

plasma, a brief discussion of the newer blood substitutes, and a consideration of the military aspects of blood plasma.

The physiology of the plasma

proteins will be elucidated under the more important therapeutic indications for blood plasma or
serum transfusion, as they pertain to that condition.
In this way it is hoped that a be t ter understanding
of the pathological physiology of the disease or
state may be reached, and thus a better appreciation of the correlation between plasma therapy and
the underlying pathological physiology.
Very few books are at present available which
present a consideration of the subject of blood
plasma with any degree of completeness, nor do these
few make an attempt to clear up controversal points.
Thus the conclusions made are largely those of the
author after weighing the subject matter in the
literature.
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II- HISTORY OF TRANSFUSIONAL SURGERY, INCLUDING THE DEVELOPMENT OF PLASMA AND SERUM FOR TRANSFUSION PURPOSES.
Like most innovations in medicine, transfusional surgery began as a heresy and was periodically
referred to as a superstition.

There is probably no

other therapeutic measure in the whole range of medical practice which has so waxed and waned in popularity throughout the centuries.

The idea that blood

contained the vital essence of life is almost as old
as medicine itself.

There is abundant evidence of

the ancient belief in the use of blood as a remedy,
the idea being that healthy blood should be used as
a-potion for the treatment of various ills.

Ancient

medicine believed that the blood not only carried the
vital force of the body, but was the seat of the soul
as well .

Old age, physical disease, as well as mental

disease, therefore, were thought to result from an exhaustion, loss, or perversion of this vital force.
Hence it was natural for these early physicians to
want to substitute new blood for old to cure disease
and to rev.i talize the body.
Pliny describes the drinking of the flowing blood
of gladiators in the arena, ttas if out of living cups",
for epilepsy.

He also describes the employment of
-3-

baths of human blood by the Egyptian kings as a cure
for elephantiasis.

Many of the ancient writers, in-

cluding Galen, who died in A.D. 201, advised the
drinking of blood as a cure for various diseases,
particularly epilepsy •

.Although it bas been claimed

that earlier authors . made reference to transfusion
of blood, it is now generally agreed that no authentic record exists of a deliberate attempt at transfusion of blood until a much later period in the
evolution of medicine.

The history of transfusion

proper has been said to have started about the year
1490, when an attempt is reputed to have been made
at Rome by a Jewish physician, Abraham Meyre, to
transfuse blood from three small boys into the veins
of Pope Innocent VIII.

The testimony in regard to

this is, however, conflicting, and there is no assurance that the Pope either received the transfusion or
drank a distillate prepared from the blood. ,G~rrison,
(1) believes the several versions of the above report
to be of doubtful origin.
After Harvey's painstaking discovery of the
physiology of the circulation in 1616, physicians
and scientists all over Eu.rope began to experiment
with transfusions.

It was not until after the middle
-4-

of the seventeenth century that the first authentic
references to blood transfusion are to be found. (2)
Francesco Folli, a Florentine physician, claimed to
have performed the first transfusion in 1654 by inserting a silver tube into the artery of the donor
and a cannula of bone into the vein of the recipient,
connecting the two by a tubing of animal blood vessel.
Christopher Wren in 1656 made a significant
step in the development of general physiology when
he injected various substances into the veins of dogs
in order to determine their possible effect upon the
organism as a whole. (3)

Nine years later, Richard

Lower performed what most medical historians acknowledge as the first successful direct artery-cannulavein transfusion of blood from one animal to another
in February 1665. (4)

The honor of the first human

transfusion, however, belongs to a Frenchman, Jean
Denys, (5), who after many experiments in transfusion
of blood from one animal to another, in June 1667,
effected the transfusion of some 600 cubic centimeters
of lamb's blood into a human patient who apparently
suffered no ill effects.
again using lamb's

A later transfusion by Denys,

blood as a fluid, ended in the

death of his patient, a ten year old boy.
-5-

During this period, Denys, probably without
realizing it, touched upon the problem, which more
than any other, was responsible for retarding the
progress in transfusional surgery, that of blood incompatability, when he noted that some of his transfused dogs, and aiso some of his sheep's blood-human
transfusion patients passed black urine.

Obviously

this hemoglobinuria was due to massive hemagglutination and hemolysis.

Religious and political con-

troversy as well as professional jealousy did much to
focus attention upon Denys, and when, as a result of
a transfusion using sheep's blood, a 10 year old
patient of his died, he was brought to trial, and the
Parisian Faculty of Medicine forbade further transfusions without their permission.

In 1678 the Paris-

ian Parliament issued an edict specifically prohibiting experiments in human blood transfusion. (6)
Although these and other early experiments resulted in the desuetude of transfusional surgery for
more than one-hundred years, this first period did
much to shed light on the desirability of employing
blood as a therapeutic measure.
-6-

The reopening of the work in transfusion was
largely due to the work of James Blundell, an
English obstetrician and lecturer in physiology.
His work marks the starting point of the clinical
application of transfusion in the nineteenth century.
(7)

Three major problems were to be met during this

period:

1. Blood coagulation,

of blood, and

2. Incompatability

3. Effective methods of transfusion.

In 1868, Hicks discovered that coagulation during
transfusion could be retarded by the addition of
sodium phosphate. (8)

With this discovery,the whole

field of chemical anti-coagulants was opened, and in
1914, Rustin, of Belgium, described a new method of
transfusion, using as an anti-coagulant, a glucose
and sodium citrate solution. (9)

It was the latter

substance, sodium citrate, which was the satisfactory answer to anti-coagulation of blood.
Landsteiner and Shattock, working independently,
in 1900 made what is possibly the most important
single discovery in the history of transfusion, by
demonstrating the presence of iso-agglutinating and
iso-agglutinable substances in human blood, thus
placing transfusional therapy on a sound basis. (10)
,..7.

Jansky, (11) in 1907, and Moss, (12) in 1910, working independently, showed that all human blood falls
into four broad groups.

These were indeed basic dis-

coveries, and paved the way for future blood transfusion without the stigma of incompatability.
Simplification of technique was the next advance, and numerous syringe methods were devised and
employed with more or less satisfactory results.
Perfection in the technique of using citrated blood
for transfusion is credited to Lewisohn, (13) in
1915, and this performance has now been reduced to a
procedure of safety and simplicity.

The transforma-

tion of direct methods of transfusion, which were employed from earliest times, up until the World War I
days, to the indirect methods, took place early in
the 20th century. (14)

Established on a sound scien-

tific footing, transfusion now began to be applied on
a mass-scale.
The problem of the availability of blood, brought
about by the wide-spread use of transfusion, has led
to several of the most unique developments in the
long history of blood transfusion. (15)

These develop-

ments include the use of blood banks, the extensive
use of preserved blood by the Spanish in their Civil
-8-

War, the use of cadaver blood in Russia, and the use
of placental blood and

dried plasma in England and

.America. (16)(17)(18)(19)

Innumerable instruments

have been devised, many of them bizarre and complicated, to facilitate the transfusion of both whole
and defibrinated blood. (20)
The earliest history of the use of plasma and
serum is more difficult to find, and is, as a matter
of fact, still being made.

Investigations of the

biologic properties of blood serum and plasma commenced with the work of H.P. Bowditch in 1871 in the
laboratory of Carl Ludwig. (21)

A large number of the

studies ma.de since that time, however, fail to make a
clear distinction between blood serum and blood plasma •
In fact, little distinction was made by the earlier
workers, between plasma and serum in experimental
transfu sion.
The earliest experimental serum transfusions were
made by Guthrie and Pike, (22), in 1907.

These men

experimented with the effects of various inorganic salt
solutions on the isolated mammalian heart in order to
determine the most suitable fluid for restoring the
heart to efficiency in situ.

They concluded that defibri-

nated blood and serum, diluted with .9% saline, were the best
-9-

of the fluids used for perfusion, and that serum, free
from corpuscles, gave better results than corpuscles,
free from serum.

Their work was confirmed by F. G.

Mann, (23) (24) who studied the effects of a number of
agents on experimentally produced shock in dogs, and
concluded that blood or blood serum showed in. many ways
their superiority over all artificial solutions.

He

further stated that in their experiments the use of
blood ~ave far better results than the use of any other
substance except serum.

During the first World War the

routine use of citrated plasma transfusion in casualty
clearing stations was suggested by Ward, (25) although
extensive use of this procedure did not follow for some
years.
The first experimental studies, comparing the advantages and disadvantages of plasma and serum, were those
of Richet, Brodin and Saint Girona.

(26)

These men

found that plasma was superior to serum in the treatment
of experimental hemorrhage.

Ma.honey, (27) obtained good

results with plasma. in the treatment of experimentally ;
produced hemorrhage and shock in 1938.

Levinson, Neuwelt

and Necheles, (28) in 1940, found serum to be more effective in hemorrhage in animals, while Magladery, Solandt and
Best, (29) were able to obtain equally good results with
-10-

plasma and serum in experimental hemorrhage.

Buttle,

(30) and his co-workers in 1940, however, investigated
the relative efficacy of whole blood, plasma, and serum
in hemorrhagic shock in animals and found whole blood
to be the best agent.

Plasma transfusions were, in

their experiments, found to be superior to serum transfusions, as they had more reactions using serum and the
rise of blood pressure was not as well maintained, as
when plasma was used.

Thus the experimental work on

animals does not appear to have established the relative
efficacy of plasma or serum.
Turning- then to clinical transfusions with plasma
and serum, Kunz, (31) in 1932 transfused blood serum
to patients suffering from acute blood loss, and stated
that he believed the results were equal to those following whole blood transfusion.

Payne and Steen, (32)

reported the use of plasma and horse serum, among other
agents, in Hemophilia, and found that the only form of
treatment that was of any real value was the intravenous
injection of either citrated whole blood or citrated
human plasma, and that fresh intravenous serum had only
a slight effect as compared to whole blood.
The earliest complete report on the use of plasma

transfusion was made by Filatov and Kartasevshij, (33)
in 1935.

These workers administered plasma obtained
-11-

from group AB blood intravenously to patients suffering from continued hemorrhage, from acute blood loss,
from burns, and from traumatic shock.

They likewise

pointed out in this report that plasma could be conserved in a refrigerator for period of from ten to three
hundred and thirty days before transfusion.

Other work-

ers, l34) in 1~37, reported reactions in from 34 to
67.6% of their patients resulting from the use of serum

and plasma obtained from universal donors and crossmatched with the recipients.

John Elliott, l35) of

Rowan Memorial Hospital, Salisbury, North Carolina,
states that he expressed the view in a preliminary
report in Southern Medicine and Surgery, in December
1936, that plasma could be preserved for long periods

and that it oould be used without typing or crossmatching.

This st nee has been confirmed by Tatum,

Elliott, and Nessett, t36) and by Strumia, Wagner and
Monaghen. t37)

In view of Elliott ts work, confirmed by

later workers, and proven by the paucity in the latest
report of post-transfusional reactions, the high incidence of reactions reported by earlier workers seems strange.
The reported low incidence of reactions of later dates may
be due to improvement in the technique of collection and
storage of plasma, and perhaps a variation in the criteria
-12-

of what constitutes a post-transfusional reaction.
To continue with a further report on the history
of blood plasma and blood serum would encroach upon
the subject matter to follow, as tnis history is indeed
still in the making.

World War II has, and no doubt

will, continue to provide many additions for the future
essayist to include in his history.
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III-PHYSICAL, CHEMICAL AND PHYSIOLOGICAL
CONSIDERATIONS OF BLOOD PLASMA
One of the ultimate aims of the chemist is to
identify, beyond question, the nature of a substance
by means of establishing its structure.

In the field

of protein chemistry, this aim is yet to be attained. {38)
Although an insight has been gained into the complex
structure of the protein molecule through knowledge of
the percentages of the amino acids, and many of the linkages of amino acids and peptides present in many proteins,
the groupings that lead to the specific characteristics of
proteins remain obscure.

The chemistry of the plasma and

serum proteins naturally constitutetLa special problem in
general protein chemistry.
In absence of essential knowledge, serum proteins
are classified on a basis of convention.

(39 )

Tb.us,

the protein of the plasma or serum that remains in solution, after half-precipitation by 21.5% sodium sulfate,
is defined as albumin.

The proteins salted out by these

means are known as globulins.

By

using lower concentra-

tions of salt solution for precipitation, the globulins
are subdivided into fradtions termed euglobulin, pseudoglobulins I and II and fibrinogen.

Tb.is procedure has

yielded information of immeasurable value in the practical
preparation of immune serums and in the vast majority of
studies devoted to the physiologic importance of the
-14-

plasma proteins.

Nevertheless, it nru.st be recognized

that the above fractions embrace a large number of
proteins with strikingly different characteristics,
and that the various components often represent loose
chemical combinations of two or more proteins.
In the last decade, three new appr oaches have
been applied to the s tudy of the plasma proteins.
These include: first, the technique of ultracentrifugation; second, electrophoresis; and third, the application
of imunochemical reactions.

The ultracentrifugation

method of studying plasma proteins developed by Svedberg
and Pederson, l40 ) allows for the determination of the
molecular weights and the purity of a given substance-in this case the plasma proteins.

Electrophoresis is a

relatively old technique, but one improved by Tiselius,
(41) and used by him to record accurately the rate of
migration of various proteins, and to separate these
fractions for subsequent analysis by other means, without altering their chemical nature by polarizing or heating
currents.

The analytical results obtained for the total

albumin and globulin fractions of normal human serums by
electrophoresis, and the conventional salting-out method,
are generally in good agreement, but marked discrepancies
appear when abnormal serums are used.
-15-

This appears to

indicate that quantitative, as well as qualitative
changes, occur in the various plasma protein fractions.
The identification of antibodies and antigens as proteins ·
of specific chemi cal nature, has also been ma.de in the
last decade.

The procedures above given, for the most

part,measure different properties of the proteins, and
it is hoped that this somewhat fragmentary review will
serve to indicate the various methods that are being
used today in study of the plasma proteins.
Blood is a highly complex fluid in which are suspended solid elements, the blood corpuscles.

If blood

is centrifuged before it has had time to clot, or if
clotting be prevented by special means, the solid elements
are thrown down and separated from the fluid portion,
the plasma.

The latter substance contains proteins as

well as many inorganic and organic substances in solution ,
nutritive and excretory materials, antibodies , hormones,
and other specific substances of unknown origin or imperfectly known chemical composition.

(42 )

Blood plasma is 54% by volume of the blood in the
male, and 58% in the female.

Its specific gravity is

normally 1.027--1.032, varying with the protein ?oncentration.

The pH of plasma is 7.3--7.4 at 38 deg.

various constituents are listed below.

(43) (44)

grams per 100 cc.

1. Water, 91-92

II

2. Solids, 8-9
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ti

c.

" "

Its

3. Protein, 7

grams per 100 cc.

a- Serum albumin, 4.4

b- Serum globulin 2.3
c- Fibrinogen,
.3

II

II

II

ti

II

II

II

ti

"

II

"

II

4. Inorganic constituents, 7-9 grams per 100 cc.

abcdefghi-

Sodium,
Calcium,
Potassium,
Magnesium,
Phosphorus,
Chlorine,
Total Chlorides,
Iron,
Sulfates,

.335
.ol
~02
.003
.003
~36
.550
.0001
.001

"

It

II

II

"

II

fl

ti

If

If

II

II

If

ti

II

"

If
II

II

11

It
It

II

"II

11

II

II

II

"II

"

"

II

II

II

5. Organic constituents other than protein,

a- HC03,
b- Non Protein N,
Urea N,
Uric Acid,
Amino acid N,
Crea tine,
Undetermined N,
c- Total Lipids,
Cholesterol,
Free Cholesterol,
Neutral f'at,
Phospholipid,
Total fatty acid,
Lecithin,
d- Glucose, apparent,
Glucose, true,

.18 grams p er 100 cc.
;036
fl
ff
11
II
If
II
II
II
.019
II
II
ti
II
.004
II
II
It
.006
"If
II
II
II
.0012
II
ti
II
.0021 II
It
II
II
ti
.6-.7
II
It
II
II
.165
II
II
II
.047
" II II
If
~154
"
ti
II
If
ti
.200
II
II
II
II
.350
II
II
II
II
.300
II
II
II
II
.100
II
It
II
II
.070

In addition to the maintenance of osmotic pressure,
which will be taken up later under the more important
therapeutic indications for blood plasma or serum transfusion, the plasma proteins have the following functions:
-17-

1.

Give viscosity to the blood which is a factor
in the maintenance of normal blood pressure.

2.

Aid in regulation of the acid base balance of
the blood.

3.

The globulin and fibrinogen fractions influence
the tendency of the corpuscles to adhere to one
another and form rouleaux or clumps.

4.

In conjunction with the action of leucocytes,
the plasma proteins form trephones which are
essential for the nourishment of tissue cells.

5.

Furnish immune substances.

These appear to be

attached to the globulin molecule.
6.

Serve as a reserve of protein upon which the
body draws during fasting or when the protein
intake is inadequate.

7.

Fibrinogen is essential for the clotting of
blood.

It is an elaboration of the above characteristics
of blood plasma and their application to modern medicine
that concerns the main body of this paper.
-18-

IV- ADVANTAttES OF BLOOD PLASMA OVER WHOLE BLOOD, AND THE
QUESTION OF SERUM VERSUS PLASMA TRANSFUSION.
For a more complete understanding of the advantages offered by plasma, it is necessary to have some
✓

knowledge of the possibilities and limitations concerning preparation, preservation and administration of
both whole blood and plasma.

These, in the case of

whole blood may be summarized as follows: (45)
1.

Whole blood has a limited and relatively short
period of preservation.

2.

Transportation of whole blood beyond short
distances involves considerable difficulty
because of the need of relatively constant
refrigeration temperatures, which can be
obtained only with the use of heavy and bulky
apparatus.

3.

Whole blood needs to be typed and cross-matched
before administration.

4.

Whole blood, if preserved more than a few hours
after collection, requires filtration before
administration.

Blood plasma, on the other hand:
1.

May be preserved for an indefinite period of
time.

2.

It is easily transported under adverse conditions
when suitably prepared.
-19-

3.

It does not need to be type or crossmatched prior to administration, if properly pooled or diluted, thus being immediately available for use in emergencies.

4.

Proper preservation, frozen or dried, prevents
fibrin precipitation and renders filtration
unnecessary.

It has been stated that one of the outstanding
advantages of plasma transfusion over whole blood is
the fact that the necessity for pre-transfusion typing
or compatability tests is eliminated.

Tatum, Elliott,

and Nessett, (46) reported as early as 1939 that they
believed plasma could be given without typing or crossagglutination.

This statement was based on ,their experi-

ence in giving 191 transfusions of untyped, or incompatible plasma, without reactions of any kind.

Another

reason for their statement was that transfusion has been
done innumerable times in the past men universal donors
or recipients have been transfused with incompatible
agglutinins in whole blood.

Throughout the years univer-

sal donors have been used for recipients belonging to other
groups, and universal recipients have received blood from
donors belonging to the other three gro1.ps, without incompatible reactions occurring, although incompatible
agglutinins have been transfused.

-20-

These authors state that

in their experience they have never had a reaction of
any kind when a universal recipient has been transfused
with blood from a donor of another group, or were they
able to find any record in the literature of such a
reaction.

They feel that the so-called "dangerous"

universal donor, referred to in the literature, are in
reality weak A 2 or B donors, and that the reactions
reported are due to agglutinogens and not agglutinins.
After a long study of the reason for using group 0
blood donors as universal donors, and group AB recipients
as universal recipients, plus their own experience with
plasma transfusions, they conclude that serum or plasma
can be given safely to its incompatibles without typing
or cross-matching.
Although practically all observers are now in agreement with this conception, there is, however, no general
agreement or understanding of why this is so.

Among the

explanations advanced for the safe transfusion of plasma
regardless of its agglutinin content is that the agglutinins are rendered ineffective by dilution. {47)

Levinson

and Cronheim, {48), on the other hand, state that this view
is inadequate.

These authors' experiments demonstrate clear-

ly an agglutinin-neutrali:zing property of serum and of all
body cells.

These findings explain both the practicability

of the universal donor and the safety of giving serum or
-21-

plasma transfusions without prior typing or compatability tests, since the neutralization of the incompatible agglutinins by the serum and tissues of
the recipient provides a wide margin of safety in
protecting the recipient's cells from the transfused
agglutinins.
It has also been claimed that the pooling of
plasma allows for a further safety factor,on the
premise that when different groups of plasma are
mixed in vitro, there is a neutralization of the
agglutinins, especially in pools containing all types.
(49)

Jakobowiez and Bryce, (50) warn, however, that

dilution may not always suffice to prevent the occurrence of reactions,as the majority of sera they tested had agglutinating properties in higher dilutions
than one twentieth.

In investigating quantitatively,

the degree of reduction of agglutinin titer produced
by mixtures of known quantities of plasma or serum
from the blood of different types, they arrived at
some interesting facts.

In mixtures of sera contain-

ing both A and B factors there is a reciprocal suppression of anti-Band anti-A agglutinins in a greater
degree than can be accounted for solely by dilution.
As this reduction in titer is due to the presence of
-22-

receptor substances of similar group specificity to the
red cell agglutinogens, it is not affected by the type O
serum, in which both red cell agglutinogens and type specific receptor substances are absent; and relatively little
by the serum of sub-group A-2 mich is characterized by
the agglutinogens of less potency for anti-A agglutinins
than for those of sub-group A-1.

In certain specimens of

type B serum, absorption of agglutinins by type A serum
occurred in less than the anticipated degree.

Thus as a

practical measure to insure the desired low agglutinin
titer in pooled serum or plasma, such pools should contain
as many individual lots of types AB, A and Bas possible,
and minimal amounts of type

o,

especially when the titer

of the latter is high or unkown.
Edwards, Kay and Davie, l51) report a method for the
preparation of a plasma free of both the alpha agglutinin of type B blood and the beta agglutinin of type A
blood, by collecting equal quantities of type A and type
B blood in the same flask.

After refrigeration for about

three days they consider that the alpha agglutinin is
absorbed on the type A corpuscles, and the beta agglutinin is absorbed on the type B corpuscles, the resultant plasma derived from this blood being free from
both agglutinins.

Tb.is method, however, would fail, should

type A blood be of the sub-group A-2, in which event
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the alpha factor of the type B blood would fail to
be removed.

They suggest as a method of overcoming

the latter, that large numbers of A and B bloods be
pooled together to insure removal of all alpha-1
and alpha-2 agglutinins by A-1 and A-2 cells.
A discussion of the methods of collection; pooling; separation of plasma from the ce l lular elements;
preparation and preservation of plasma in its several
forms; the effects of these methods of preservation
on the safety of the plasma and the certain specific
elements of plasma; the advantages of the use of
certain types of plasma;and methods of administration
of plasrna,follows.

However, before entering upon this

discussion, since the relative values of serum and
plasma have been, and are being, widely discussed,
and since facts concerning the efficacy of one over
the other have not been establ ished, a review of this
problem will be dealt with first.
Some workers have obtained better clinical results
with plasma.

Ravdin, (52) in discussing the nutrition of

surgical patients states that the prolonged restriction
of protein intake results in a deficiency of the labile
protein stores, these often being reduced to the zero
point by long continued anemia or bleeding during periods
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of protein restriction.

He has used plasma trans-

fusion and lyophile serum for the above and other
conditions of hypoproteinemia, and considers that
one should hesitate to use lyophile serum generally,
due to the frequency with which reactions occur.
Ravdin, (53) also records some very annoying reactions
characterized by chills and fever in the use of lyophilized serum and states that "until the cause of
these reactions is ascertained, lyophile serum will
have a limited usefulness".

McGuiness, Stokes and

:Mudd, (54) in studying the results of serum produced
by the lyophile process on the prophylaxis and treatment of the common infectious diseases, noted that
they obtained severe reactions following its use,
and sugges t that these are mainly due to the presence
of hemolyzed cells in the serum.

Aldrich, (55) and

his co-workers noted reactions accompanied by chills
and high fever in two out of nine injections of serum,
and mild febrile reactions in others, lasting only a
few hours.

Brennan, (56) reports that he considers

plasma transfusion should b e adopted as a routine
measure in the treatment of severe hemorrhage, and has
obtained good clinical results with its use.

Black, (57)

says in studying the effects of serum and plasma trans-25-

fusions in burn shock, "great clind.cal improvement
followed infusion of dilute plasma accompanied by a
rise in plasma volume".

The results with serum are

reported as being much less favorable.
Other workers have obtained better results using
serum.

Levinson, (58) and his co-workers note that

while other workers report reactions using serum, they
were able to give 47 serum transfusions for various
conditions including shock, hemorrhage, burns, cachexia
due to infection, pneumonia, acute catarrhal jaundice,
generalized septicemia and chronic blood loss,with a
reaction in only one instance, consisting of local
pain along the course of the vein into which the serum
was being injected.

They noted no reactions of a pyro-

genic nature and no blood group incompatibility.

They

attribute the reactions of other workers as being due
to improper preparation of the serum and state, "there
are no great differences between plasma and serum as
transfusion fluids".

Oleg and Dibble, (59) administer-

ed serum in quantities up to 1600 cc to a variety of
cases including post-operative shock, hemorrhage, severe
hematemesis, traumatic shock and normal subjects obtaining results "fully as good as those following transfusion
with other fluids".

They do mention the development of
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a reaction in one subject however.

McMichael and

Schafer, (60) report good clinical results using
serum in various clinical conditions similar to the
above, and make no mention of any reactions.
Mellanby, (61) reports from England that serum is
preferable to plasma mainly because it can be sterilized by passage through a Seitz filter.

Strumia, (62)

states that "the question of the use of serum versus
plasma has been unduly magnified and often misunderstood".

He agrees on the similarity of certain thera-

peutic actions of plasma and serum as is evident from
the literature, but gives preference to plasma., since-(1) a greater yield of plasma can be obtained than
serum, (2) the production of plasma can better be
coordinated with the functioning of a blood bank,
and (3) reactions to administration of properly preserved plasma are unknown, save for rare mild urticaria.
As to the disadvantage of plasma pointed out by certain
workers, as Mellanby above, that it cannot be conveniently filtered through a Seitz or similar filter
for purposes of sterilization because of clotting, he
points out that such filtration is made unnecessary by
the adoption of a closed system for the collection,
separation, pooling and distribution of plasma and by
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adequate checks on the sterility and toxic properties
of plasma by means of cultural studies and innoculation of material into mice.

This objection may also

be made les s significant by the addition of sulfonamide drugs into the plasma to insure sterility.
The reason for the difference in the effect of
plasm.a and serum is not clear, although a clue is
provided by the work of Stevens and Lee, (63) who
noted that vasotonins were more apt to appear in the
blood serum than in blood plasma.
firmed Stevens work in 1903.

Brodie, (64) con-

When it is realized that

some of these substances are vasopressor and vasodepressor, the differentiation of serum from plasma
takes on a new significance. (65)

Stewart and Harvey,

(66) investigated one of these vasodepressor substances
in 1912, and came to the conclusion that it was a
protein of the albumin type.

Freund, (67) suggested

that one of these vasodepressor substances might be
derived from the blood platelets, and this substance
was found to be adenosine phosphoric acid by Zipf and
Fiske, (68).

Freund also found that these vasotonins

may disappear from the blood within 24 hours, but
Bayliss and Ogden, (69) found they frequently persisted
for an indefinite period.
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It is thus apparent that

vasotonins are more likely to be present in blood
serum than in blood plasma and this fact may explain
the higher incidence of reactions with the former.
As regards the sources and causes of post-transfusional reactions, Davis, (70) considers that they
may be due to incomplete inactivation of the group
specific isoagglutinins of the plasma or serum by
the body fluids or tissues of the recipient resulting in agglutination of the recipients red blood cells.
Gleg and Dibble, (71) suggest an allergy since occasional reactions of an allergic nature, as urticaria, develop.
These same workers and Drew, (72) have roted a high
potassium content in the preserved serum or plasma.
Other suggestions, (73) are: (1) bacterial contamination;
an undetected contamination might easily account for
reactions, (2) denaturation of the proteins;

this may

occur from too rapid or excessive heating of the plasma
or serum prior to transfusion, (3) high content of hemoglobin; the maximal quantity of free hemoglobin in solution should not exceed 25 mg. per hundred cc. of plasma
or serum, and (4) improper preservatives a~phenol.
Thus we have one group maintaining that serum is
preferable, because of the absence of the formation of
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precipitates on standing,and because it lessens the
chances of c ontamination.

A second group prefers

plasma because it is maintained that its use is associated with fewer unfavorable reactions, and a higher
yield can be obtained than in the case of serum.

Still

a third group maintain that plasma and serum are equally
good.

Many points concerned with the choice of plasma

and serum remain to be settled.

However, as long as

care in preparation is used, it appears one may employ
either,with lit t le danger of untoward reactions.

In

summary, the words of the Council on Pharmacy and Chemistry of the American Medical Association may be taken
in answer to this complex problem--"the results of
human transfusion do not appear to have established
the relative efficacy of human plasma and serum transfusions".
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V- PROCESSING OF BLOOD PLASMA
A- Methods of collection of blood plasma.
Plasma, for subsequent transfusion, either before or after preservation, may be separated from
whole blood collected for that purpose alone, or from
preserved whole blood which has passed the age limit
for safe use.

There are a good many controversal

points about the collection of plasma yet to be
solved; however, it is generally agreed that rigid
asepsis is imperative.

There is no doubt that this

may be achieved best by use of vacuum bottles, both
for the collection of the original whole blood, and
as a container for the separated plasma.

By using

such a system, Elliott, Busby and Tatum, (74) demonstrated no organisms on culture of 150 specimens of
plasma, some of which had been stored at room temperature for as long as 18 months.
The methods employed by Strumia, (75) in ~he
collection of blood are worthy of mention.

A detailed

and complete discussion is given on technique and
methods of collection of blood from donors.

He

particularly stresses the importance of making all
procedures absolutely "closed" to reduce the possibility of contamination.

To further this end he
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describes in detail a "blood taking bottle" which
is an 850-cc Pyrex bottle with a short neck, 26 mm.
in diameter, fitted with a special hooded two-hole
amber rubber stopper, and connections which completely protect the path of the blood against contamination.

'To.is bottle can be adapted to the

vacuum method, if desired, by creating within the
container a vacuum, by suction on the air filter
tube attached to the bottle, and then clamping this
off.

An alternative is commercially available by

use of the "Centrivac" bottles, 300 cc containers
with a pre-formed vacuum, which can be adapted to
the centrifuge by special cups and heads available
with these bottles. (76)

The "Centrivac" bottle

comes accompanied by the necessary apparatus for
bleeding, and contains 35 cc of 2.5% sodium citrate
solution.

After separation of the plasma by centri-

fugation, the plasma is drawn off by a pre-formed
vacuum, into a similar centrivac bottle, wl.thout
citrate, using equipment provided with the set.

Its

disadvantages are mainly the expense involved, the
somewhat smaller yield, the occasional failure of
the vacuum from improper handling, and the lack of
protection for the aspirating cannula.

As regards

the donor, Strumia stresses the need for an adequate
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pre-letting physical examination and laboratory examinations as indicated, to rule out diseased donors.
The preferable age limit for donors is between 21
and 45, and no donor is used in whom the hemoglobin
level falls below 13 grams.

The quantity of blood

taken is determined by the patient's weight in proportion to 3-5 cc of blood for each pound of body
weight for males, and 3 cc per pound for females,
(maximal quantities).

The prospective donor should

be advised to avoid a meal during the four hours preceeding bleeding, and should be encouraged to drink
three to five glasses of a non-fatty liquid.
The methods employed by Scudder, (77) in his
wide experience with the Blood Betterment Association, in the collecti~n of blood for the British,
give satisfactory results but are considered by him
as a make-shift procedure, and he is of the opinion
that dried plasma is the answer to the problem.

In

his method, "blood is drawn from voluntary donors into 235 Ml. centrifuge tubes; it is chilled in the
refrigerator and placed in a chilled centrifuge; the
plasma is withdrawn by suction the next morning into a flask in which various plasmata are mixed.

The

bacteriologic study is immediately instituted, and
should the report come back after 72 hours, that the
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plasma is sterile, both as to aerobic and anaerobic
tests, we then siphon off 500 cc into Baxter plasmovacs of the 1,000 cc variety.

These flasks already

have in them 500 cc of physiologic salt solution.
It is this mixture of plasma that we are sending to
England."
The storing of blood thus collected, for any
length of time over the minimum necessary for the
procedure of choice, in separating the cellular
elements from the plasma, is to be avoided as much
as possible.

St~umia, (78) considers that five days

of storage of whole citrated blood should be considered as the maximal time, and that separation and
fixation of plasma should take place before the end
of this period.

Plasma, either fresh or fixed, with-

in a period of 24-48 hours from time of blood collection, is a far superior product, even a different
product, than that which is kept in the liquid state
for longer periods of time.
Separation of the cellular elements from blood plasma.
Two methods may be employed for separation of
cells from plasma--spontaneous sedimentation, and
centrifugation.

'l'he former yields a volume of plasma

equal to approximately one-third that of the original
whole blood-citrate mixture, whereas after centrifugation, the volume of plasma obtained is usually somewhat
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greater than one-half the original volume. (79}
Sedimentation Method
In this method, collection of the blood is done
with the same donor bottles, using the same technique
as in the centrifugation method.
allowed to stand at 4 deg.

c.

The blood is then

for a period of up to

seven days for maximal yield, or a shorter period of
five days for better preservation of the more labile
elements.

The plasma is then drawn off with the

apparatus previously described.

The chief difference

from centrifugation will be a small yield, and if
sedimentation is prolonged, a loss of the more labile
elements, particularly prothrombin.

Even more impor-

tant is a chance contamination if the blood is allowed
to stand for several days.

Plasma obtained in this

manner must be absolutely proven sterile by culture,
before use.

This method is best adapted to hospitals

where plasma is a sole by-product of the blood bank,
rather than obtained from fresh blood. (80)
Elliott, (81} in 1936,used a vacuum tube, sealed
at both ends with rubber, which could be perforated
with a needle for collecting blood.

After the period

of safety for whole blood storage had elapsed, the
rubber at the bottom was perforated with a needle,
the cells drawn off, and the plasmathenpreserved in
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the original tube for an indefinite period.
Scudder, Bishop and Drew, (82) used an hour glass
container, drawing off the plasma ai'ter a week, into
separate containers.

While this method has the ad-

vantage of a small interface, due to the hour glass
constriction of the container, the plasma runs the
risk of contamination in being removed from one
bottle to another.
Sturgis, (83) prefers the spontaneous sedimentation method despite the smaller yield because-(1) less special apparatus is required; (2) heating
and trauma of the blood in connection with centrifugation are avoided, thus reducing hemolysis; and (3)
fewer manipulations reduce the chances of bacterial
contamination.

He suggests that the plasma be sep-

arated from the cells after 48 hours of spontaneous
sedimentation at 4 deg. c.
Centri.fugation Method
If centrifugation is employed, Strumia, (84)
advises chilling the interior of the centrifuge with
a source of cold air (air-conditioning apparatus or
dry ice).

He justifies the use of the centrifuge over

spontaneous sedimentation by the fact that: (1) a
higher yield of plasma is obtained; (2) the conven-36-

ience of centrifuging the blood in the same bottle
in which it is collected; and (3) the minimal heating
of the blood specimen without
tus.

~

ecial cooling appara-

The high speed centrifugation closely packs the

cells and causes formation of a viscid coat of leucocytes.

This acts as a protective covering for the

erythrocytes and allows drawing off a much larger
quantity of plasma practically cell-free.
Elliott, (85) and his associates recommend that
the centrifuged mixture be placed in the refrigerator
for twelve hours before aspirating the plasma in order
to further reduce its cell count.

They also state that

gross precipitates are apt to form in plasma after its
separation from the cells, and recommend that the quantity of these can be reduced by using fasting donors,
by separating the plasma from stored blood rather than
fresh blood, by dilution of the separated plasma to
approximately the original blood volume, with physiologic saline containing glucose, and by the addition
of merthiolate to a final concentration of 1:lo,ooo.

In order to get rid of further precipitates or the usual
fibrin "veil", which forms in aging plasma, it should
be filtered at the time of transfusion.
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Crowley, (86) combines the advantages of the
hour glass container of Scudder, and the vacuum bulb
tube.

He uses a double bulb with a narrow neck or

crossbar about two inches long which has a projection upward from the top of one of the bulbs (thus
dumbell-shaped with the crossbar extended beyond
one of the bells) made of sodium glass of low melting point and containing the correct amount of citrate
solution.
clave.

This double bulb is sterilized in an auto-

Drawn blood is introduced directly through

the open tube at the top of one of the bulbs to the
bottom of the other bulb with a long filling needle
below the citrate level.

The two bulbs are filled,

but the volume of the lower bulb is such that after
centrifuging, the cell~plasma interface, preferably,
will be in the connecting tube.

The open top is flame-

sealed, the two bulbs centrifuged, the crossbar scored
with a file and broken at the plasma-side of the
interface, the plasma-containing top bulb inverted,
and the just-opened end of the crossbar sealed.

For

administration, either end of the glass-sealed plasma
chamber is opened, attached to an intravenous outfit
and the other end opened.

A filter should be used.

The plasma chamber can contain 250 cc.
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This method

combines the advantages of preservation in the original container with small cell-plasma interface.
Strumia, (87) and his associates seem to have
overcome many of the objections to the centrifugation
method cited by some authors, especially the important point of possible contamination.

In their

method, the blood, immediately upon collection, or
at least within one hour, is placed in a refrigerator
at 4 deg. c., and kept there until it is used or the
plasma separated.

They state that it is essential

to shorten, as much as possible, the time interval
between the collection of the blood and the separation and "fixation" of plasma.

By "fixation" is meant

freezing, followed, or not, by drying.

Tbis shorten-

ing of the time interval between the collection and
separation of the plasma avoids the possible bacterial growth should minor contamination have occurred
from the skin of the donor or other sources.

If the

plasma is to be kept in a liquid state, even greater
precaution should be taken to prevent contamination
than if it is to be frozen or dried.

Following re-

frigeration the citrated whole blood, contained in
the special "blood bottle" above mentioned, is placed
in a specially designed centrifuge, and the cellular
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elements thrown down.

A run consists of 58 minutes,

which secures maximal packing of the erythrocytes.
A maximum of from 28 to 32 bleedings can be centrifuged in an 8 hour day by one worker.

The a.mount of

plasma separating from the cellular elements is,
however, not the amount which may be drawn off, as
it is impossible to remove all the supernatant fluid
without disturbing the cellular elements.

This yield,

however, is greater than in the spontaneous sedimentation method, as the cells in the latter method are
not tightly packed, and no buffy coat of white cells is
apparent.

Co~sequently the volume of supernatant fluid

left behind in the process of removal will be greater
in the sedimentation method because the sedimented
cells are more easily stirred.

The percentage of

citrated plasma actually recovered by the centrifugation method varies from 33 to 58.1% among different
workers.

c-

Pooling of blood plasma.
The pooling of plasma thus collected and separat-

ed from whole citrated blood, has been found to be
desirable for the following reasons:
1.

It §ssures dilution of an occasional specimen
with an unusually high isoagglutinin titer.
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'
2. Because it yields a more uniform prqduct.
-~

3. Because it would not be practicable to insti-

\ plasma specitute bacterilogical controls on
mens from single bleedings, particularly when
plasma preparation is done on a large scale.
Experience has shown that a pool of ten bleedings
of citrated plasma averaging 300 cc. each is satisfactory.
With pools of this size, and the individual blood specimens not too small, the average total protein content of
the citrated plasma is 6 grams percent.

300 cc. of the

plasma will contain 17.5 grams of protein, the amount
considered as a convenient standard dose, or "unit",
and approximately the amount obtained from 500 cc. of
citrated blood.

T.he size of the pool is necessarily

limited by the fact that the larger the pool, the great~
er the danger of contamination, and the greater the loss
in case of contamination of a single specimen. ~Strumia
and McGraw, 87)

',

~tis interesting to note that the time of collection influences the appearance and properties of pooled
plasma.

That collected in the morning hours from women

is clearer and rarely gives urticarial reactions, probably because these women have observed the precaution to
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fast before blood is collected.

On the other hand,

this plasma is lower in protein content because the
bleedings are smaller and the ratio between blood and
citrate solution is therefore lower.

Blood collected

from males between the hours of 5 and 9 P. M. usually
contains more lipids, is richer in total protein and
more likely to give urticarial reactions in allergic
recipients.
It is advantageous to follow centrifugation by
drawing off and pooling the plasma within 8-10 hours,
as after this time, interval filtration of plasma prior
to fixation is usually neces s ary.
An apparatus suitable for the production of pooled

plasma on a relatively large scale is presented herein
as taken from Strumia and McGraw, (foregoing).

The

drawing off, pooling, and distribution into individual containers is all accomplished by means of a closed
system.

Essentially, the apparatus consists of a pool-

ing bottle, 4 L capacity, an aspirating cannula, and a
distributing burette and cannula assembled as a single
unit.

The pooling bottle is fitted with a tight two-

holed rubber stopper, one outlet providing for venting
and attachment of a vacuum or air pressure as needed.
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The other outlet is attached by means of a T-tube
to the distributing burette and aspirating cannula
respectively.

The latter embodies certain features

which enable one to protect the plasma against contamination,and allows for indirect handling of the
cannula for transfer from one bottle of collected
and centrifuged blood to another.

During the draw-

ing off of the plasma from the bottle into the pooling bottle, accomplished by setting up a vacuum in
the latter by means of a pu..-rnp attached to the air
vent, the distributing burette is excluded from the
system by a stop cock connection near the T-tube.
When the desired number of specimens are pooled, the
distributing burette system is used to obtain samples
of the pooled blood for cultures, total protein determination and other examinations desired.

This is

accomplished by establishing positive pressure within
the pooling bottle and forcing the plasma into the
distributing burette,which has meanwhile been opened
to the circuit by opening the stop cock in the T-tube.
This same system is utilized for distribution of the
pooled plasma into individual containers after tests
have shown it is satisfactory for further use.

The

plasma is now in its final container and ready for
preservation by any of the various methods described
below.

This apparatus is considered suitable for a
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hospital with an average occupancy of 250 patients>
and an active surgical service using the plasma of
about 1,000 donors yearly.
D.

Preservation of blood plasma.
A number of methods have been described for the

preparation and preservation of citrated plasma, all
perhaps capable of modification, and all possessing
various advantages and disadvantages in accordance
with the circumstances at hand.

It is difficult, if

not in some degree impossible, to select a single universally applicable method, (88) and thus a number of
those which have proven satisfactory will be described.
Plasma may be preserved in one of four forms:
(1) liquid plasma;

(2) frozen plasma;

(4) concentrated liquid plasma.

(3) dried plasma;

The latter preparation

can be readily prepared from dried plasma, however, and
thus there is little reason for exploiting its preparation and preservation.
Preservation and s~Q.r~age in the liguid~state.
The preservation of liquid plasma by keeping it
under refrigeration at 4 deg.

c.,

plus the addition

of 1:10,000 merthiolate i mmediately after pooling has
been advocated by Strumia and McGraw. (89) These men
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and other workers, however, later found that merthiolate addition in the above proportion, does not completely eliminate the danger of reactions from contamination, particularly when the plasma has been separated from the blood which has been stored for a number
of days in a blood bank.

(90)

They record five severe

pyrogenic reactions following administration of plasma
from a lot thus preserved and later proven to be contaminated.

Sturgis and Scudder, (91)

likewise have in-

dicated that merthiolate is not a reliable preservative
for plasma which is kept at room temperature.

Elliott,

Busby and Tatum, (92) state that refrigeration is preferable to merthiolate, but have, nevertheless, administered fifty three samples of plasma which had stood
at room temperature for from 1 to 270 days, some of
which had been transported by various conveyances for
as far as 17,000 miles, without encountering any untoward reaction.
The storage of plasma in the liquid state at room
temperature is not, however, a desirable means of preservation because it allows bacterial growth from a
chance contamination, and a progressive degeneration
of certain elements of plasma.

This degeneration is

evidenced by the gradual loss of prothrombin and complement as well as the appearance of a flocculent
-45-

precipitate consisting mainly of fibrinogen.

(93)

Scudder, {94) believes that the electrophoretic
pattern of unrefrigerated stored plasma is not normal.
Presumably, some sort of gradual denaturation takes
place in liquid plasma not kept at a low temperature,
although the extent of this, and the degree to which
it renders the plasma unsuited for transfusion, has
not been clearly defined.
Novak, {95) very recently, has stated that the
dangers of contamination of plasma stored in the liquid state can be completely eliminated by the addition
of .2% sodium sulfathiazole.

This substance exerts its

bacteriostatic effect under all conditions of processing and storage.

It is most convenient to draw blood from

the donor directly into a solution containing both sodium
citrate and the sodium sulfathiazole.

The solution

consists of 1.5 gm. of sodium citrate and 1 gm. of sodium sulfathiazole sesquihydrate in 50 cc. of physiologic
saline.

This solution is autoclaved in the regular flask

into which the blood is to be drawn.

This amount of

sulfonamide drug gives a final concentration of .2%
when 450 cc. of blood is added.

The plasma may then

be separated by centrifugation or sedimentation.

When-

ever tests for sterility are desired they should be
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made with mediums containing para-aminobenzoic acid
to neutralize the bacteriostatic action of sulfathiazole as ~uggested by Janeway and Shwachman, (96) and
Hunwicke. (97)

This method of preservation obviates

the elaborate and expensive methods for routine processing of plasma and produces a liquid plasma safe
from bacterial contamination regardless of the organism or the storage temperature involved.

The proced-

ure,while entirely feasible,lacks, at present, the
necessary confirmation of other workers.
The addition of calcium chloride to plasma in
the liquid state to eliminate the precipitation of
fibrinogen has been proposed as a method of preservation by Cleg and Dibble.

(98)

Strumia and McGraw,

however, consider this additional procedure unnecessary if immediate fixation of fibrinogen by freezing
is done. (99)

These authors consider the storage of

plasma in the liquid state to be undesirable because:
(1) it is dangerous from the standpoint of ease of
bacterial contamination, with the development of pyrogenic organisms, and (2) it allows the deterioration
of plasma to take place with loss of prothrombin, complement and fibrinogen, the latter forming a precipitate
which must be removed before use.
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Preservation and storage in the frozen ~s_tate.
As early as 1932 it was noted by Strumia, Wagner and Monaghan, (100) that some of the more labile
properties of plasma could be effectively preserved
by keeping it in the frozen state, and that certain
precautions only,need be observed in thawing such
plasma, in order that it be used intravenously without adverse reactions.

The earlier methods of freez-

ing and thawing used by these workers were imperfect,
and all owed the flocculation of fibrinogen, thus preventing the adoption of freezing as a routine procedure at that time.

Later -studies and improvement in

methods entirely eliminated this problem.
method is herein outlined.

Their later

(101)

'lhe containers for storage in the frozen state
must be chosen with the following pre-requisites: (1)
they should allow filling through a perforable rubber
stopper to maintain a closed system; (2) they should
allow for administration through the original stopper
after freezing and thawing; (3) they should be of a
low solubility glass with an evenly thick wall to
assure considerable mechanical strength and permit
uniform heat conduction during free~ing; (4) they
should have a capacity at least one-third larger than
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the amount of plasma to be stored.

Practically it

is not advisable to freeze a mass of more than 600
cc. of plasma in one container as it would require too
much time to thaw.

The authors describe in detail

the bottle they have adopted as a standard container.
Freezing is simply accomplished by placing the bottle
containing the plasma on a slant in a freezing cabinet.

Cabinets such as intended for the storage of ice

cream, capable of maintaining temperatures of from
-15 to -20 deg. c.,are well suited for this purpose.
The temperature of freezing is not critical as far as
the preservation of the essential properties of the
plasma are concerned,but should be sufficiently low
to allow freezing of the plasma in about three hours.
A temperature of about - 10 deg. c. is sufficient for
freezing of 300 cc. of plasma in this time.
"Shelling", a process first used by Reichel, (102)
in 1931 is almost essential for the process of drying,
but is not necessary if the plasma is kept in the frozen state.

If used, however, it does allow for a short-

er thawing period, which might be of advantage in some
conditions.

The process of shelling is carried out

simply by laying the bottle in the freezing cabinet
at an angle, and rotating the bottle occasionally to
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a new position.

It is essential to have a shell of

uniform thickness and absolute freedom of ice in the
neck of the bottle.

Rotation of the bottle can be

accomplished either by manual or mechanical means.
Plasma, once frozen, must be maintained at a
temperature well below the melting point if preservation is to be adequate.
-15 and -20 deg.

c.

Temperatures ranging bet~een

have been found to be optimal. (103)

(a) Thawing and preparation for administration
from the frozen state.
Plasma properly frozen, maintained in the frozen
state for indefinite periods, and rapidly thawed to
toom temperature in a water bath at 37 deg.

c.,

results

in a clear fluid indistinguishable from the original
material.
37 deg.

(104)

c.,

Heating to temperatures higher than

however, is to be avoided because of the

danger of reactions.

Th.awing of the plasma requires

~

careful adherence to a definite technique to prevent
the formation of a fibrin reticulum.

This is noted

in fresh citrated plasma left standing for a short
time at or about 4 deg.

c.,

or fresh plasma which has

been properly frozen but thawed slowly.

Upon removal

from the storage cabinet, the frozen plasma is irmnediately immersed in a water bath at 37 deg. C. and kept
-50-

in it, ~ith occasional gentle shaking, until complete
thawing.
half hour.

This should be accomplished in about oneFollowing the disappearance of the last

trace of ice, the plasma is allowed to remain in the
water bath for a period of from 5 to 10 minutes, according to the quantity, to allow it to warm rapidly to
room temperature.

Precipitates may occur if allowed to

reach room temperature slowly, or if after proper thawing, it is again cooled to 4 deg.

c.

It is, therefore,

necessary to keep the plasma at room temperature after
thawing until ready for administration.

Under these

conditions the plasma remains sufficiently clear for
administration for several days without filtration.
Properly thawed plasma may be re-frozen without apparent deterioration, and if due to accident, slow thawing occurs, the resulting precipitation may be filtered out and the plasma safely administered.
In connection with precipitates, the report of
Mayner , (105) is of interes t.

He transfused a patient

of his, a four year old child, with from 90 to 100 cc.
of plasma, and the child suddenly became dyspneic and
died.

He notes no fatality due to plasma transfusion,

other than this, in the English medical literature from
1924 to 1940.

Microscopic
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examination of tissues removed at autopsy showed
the presence of multiple emboli of fibrin in the
terminal pulmonary vessels and capillaries.

In

this connection it should be noted that neither
during the preparation of,nor in the administration
of the plasma,was a filter used .

Lewis, (106)

reports that in t~e opinion of Drs.

w.

B. Cooksey,

Armand Quick,and M. M. Strumia, to whom sections
of the lungs were submitted for study, the fibrin
emboli found were only in the capillary system of
the lungs and came preformed from unfiltered plasma,
rather than having been formed after the plasma was
introduced into the patients circulatory system.
(b) Administration.
It has already been stated that it is desirable
to use for the preservation of plasma in the frozen
state, a bottle and a stopper which will allow the
administration of the material without transfer.
This may be accomplished in a variety of ways: by
use of the above- mentioned standard bottle, by the
adaption of standard laboratory glassware, or by the
use of apparatus commercially supplied for this purpose, such as the 600 cc.

11

Plasmvac", or "Centrivad'.

A sterile unit consisting of a short 16 gauge con-52-

necting needle, fitted to a length of rubb er tubing
terminating in a glass needle adapter, to which an
18-20 gauge needle is fitted, is needed for administration.

When ready for administration, the bottle

is fitted in a sling, the connecting needle inserted
through the perforable rubber stopper in the bottle,
a screw clamp fitted to the tubing and the bottle is
inverted.

A sterile hypodermic needle may be insert-

ed into the rubber stopper to one side of the connecting needle to allow air to enter the bottle, or _a ,,regular air vent may be supplied.

Several successive

doses may be administered through the same tube, without disturbing the needle from the pati.e nt •s vein, by
simply closing the screw clamp and transfe.rring the
connecting needle from the bottle top and inserting
it into a fresh bottle.

(107)

{c) Advantages of frozen plasma are, that:
1.

It is easily prepared.

2.

It is economical.

3.

It is easily stored and transported, because
of the wide range of the temperature of preservation, as long as it remains frozen.

4.

It retains its content of the most labile
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elements, such as prothrombin w;thout significant losses and remains sterile.
5.

It does not require addition of water for restoration as opposed to dried plasma.

6.

It is clear and ready for administration without filtration when it is properly thawed.

7.

Drying may be accomplished from the frozen
state if desired.

Freezing of plasma and keeping it in the frozen
state as a means of preservation is probably the method
of choice, meeting the essential requirements in the
greatest number of instances.

It has been estimated

that preservation of plasma in the frozen state would
take care of at least 90% of the needs of most institutions.

(108) (109)

Pre12.ar_ation of G_oncentrated and Dried Plasma
Among the outstanding advances in the study of
plasma transfusion has been the development and application of the method first described by Flosdorf and
Mudd, (ll0) for the preservation of serum 1n desiccated form, to the preparation of desiccation and
concentration of plasma.

Plasma dried from the frozen

state has definitely been shown to be a dependaole
material, free of reactions, and convenient for rapid
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restoration and administration, (111).
Many new methods nave been proposed for the
.

drying of biologic suostancos in the past few years.
(112) (113) (114) (115) (116) (117) (118) (119) (120)
Strumia, McGraw, and Reichel, (121) in a brief history
of the development of drying of biological materials,
conclude that in the first decade of 19uo, the workers
in the field of drying biological substances, laid
down all the essential principles applied today, although apparently most of them are seldom mentioned
by those interested in assembling apparatus for the
same purpose today.
Irrespective of what methods of desiccation are
employed, the resulting product must be rapidly regenerable as a sterile protein solution, whose original colloidal characteristics have not been material•
ly altered.

Inasmuch as in treating shock, the pri-

mary aim is restoration of blood volume, preservation of the more labile components of plasma, such
as prothrombin, complement and so for-t h , if of
secondary importance, although in the case of certain
methods, notably those involving vacuum sublimation,
these factors are largely unaffected.

The preserva-

tion of the more labile elements above mentioned,
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however, is an important consideration in the therapeutic use of plasma transfusion for conditions other
than shock, as will be mentioned later.
Methods of producing such dried protein material
may roughly be divided into four catagories or combinations of these, as follows:
1.

Spray distillation in vacuo (method of evaporation)

2.

Evacuation from the frozen state (method of
sublimation)

3.

Permeation of water through cellophane or
collodion membranes (method of pervaporation)

4.

Miscellaneous methods:
(a)

Dialysis against acacia.

(b)

Alcohol-ether precipitation of
proteins.

Vacuum sublimation from frozen plasma. or serum,
first described by Shackell , (122) in 1909, appears
to produce an almost ideal dried product.

An

excel-

lent discussion of vacuum sublimation is to be found
in a paper by Greaves and Adair . (123)

Elser in

1934, and Elser, Thorn.as and Steffen in 1935, (124)

described a process and apparatus for desiccating
liquid and semi-solid biolog ical substances.
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The

process consists essentially of high vacuum-low temperature condensation, quite similar to that which
Bordas and d'Arsonval described in 1906.(125)

A

great deal of the special apparatus now used for drying substances from the frozen state in vacuo,owes
much to the pioneer work of Elser in this field,
however.

.

Several . processes have recently been described,
in which the principle of vacuum sublimation is utilized, the plasma being either prefrozen or frozen
by the heat loss from evaporation in the early stages
of the process (snap-freezing), and the frozen state
is thus maintained until dehydration is nearly completed without additional chilling; indeed, heat may
be applied with advantage to prevent too great a fall
in the temperature, and hence a concomitant change in
the vapor pressure of the subliming solid.
(1)

The "Lyophile n process, described by

Flosdorf and Mudd, (126) is an improvement of similar
procedures of antecedent workers as Elser, Thomas, and
Steffen, (127) and Greaves and Adair. (128)

The pro-

cedure is essentially one in vhich, by removal of the
water content under vacuum, the serum, or plasma, is
desiccated to a dry powder.
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In this state

it

can be

preserved in vacuo indefinitely and can be restored
or reconstituted with all its properties unchanged,
by restoration of the fluid content through the addition of distilled water.

The process utilizes the

removal of water vapor in vacuo by condensers maintained at the temperature of solid carbon dioxide
under a pressure below .2cm by means of a special
apparatus.
(2)

In a further development, the "Cryochem 11

process, originated by Flosdorf and Mudd , (129)
anhydrous calcium sulphate is used as a dehydrating
agent, instead of sulphuric acid or phosphorus pentoxide as used by their predecessors, to effect the
removal of water vapor from the ' system.

In this

process the pressure may vary from 1 to 2 cm.
(3)

Later Hill and Pfeiffer, (130) described

the '" Adtevac" process which consists of evacuation of
serum or plasma from the frozen state, utilizing
silica gel as a dehydrating agent to adsorb the
water vapor in the system.

The anhyrous gel may be

readily regenerated for further use.
(4)

A still further development has been de-

scribed under the name of the "Desivac" process by
Flosdorf, Stokes and Mudd. (131)

This process is

more economical and efficient than the "Cryochem"
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process, and is applicable to the processing of larger
quantities than can be eff iciently handled by the Cryochem process.

The Desivac process removes water vapor

by permiting the vapor to flow directly into the oil
of a high vacuum pump, the oil in turn circulating
through a cont inuously operating centrifuge which separates and removes the aqueous phase.

The pump is rel-

atively large in order to remove the volume of vapor
which is great in {:Ip it e of the fact that the operating
pressure is somewhat higher than that of the other
processes.

Practically all of these methods require

special and relatively expensive apparatus, ~he details
of which it is not necessary to discuss here.
In addition to the procedures

above described,

three other methods used for dehydration of plasma will
be mentioned :
1.

Simple vacuum distillation may be employed to

desiccate plasma as described by Edwards, Kay and Davie,
(132) and by Harper, Essex and Osterberg.

(133)

Tile

product from this and similar methods, is usually a
hard, slowly soluble, scaly mass, which must be ground
before it will go readily into solution.

The product of

Harper, Essex and Osterberg is stated, however , to be
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flaky and easily soluble.

The avoidance of contami-

nation and the prevention of denaturation are difficult
problems when this method is used, but it is a simple
and cheap method of production of desiccated plasma.
2.

Plasma may also be readily concentrated or

dried by evaporation in a current of air, from the
fluid, contained in col l odion or cellophane bags. (134)
(135) (136)

The resulting product does not easily go

back into solu tion with out preliminary pulverization.
This method, h owever, does have the advantage of cheapness, simp licity of apparatus, which can be installed
in any laboratory on almost any scale, low ?perating
cost, and requireslittle personal attention.
3. Labile proteins may be dehydrated without dena-

turation by brief precipitation at low temperatures from
organic solvents such as acetone and methyl alcohol.
The excess solvent is readily removed in vacuo

(137)

leaving a powder or porous cake of protein, which may
be quickly reconstituted in its original form by addition of water, providing the precipitation process has
been carefull y controll ed.

Tb.is procedure, to my lmow-

ledge, has not been used for the preparation of dried
human plasma or serµm for subsequent transfusion pur.- ··
poses.
In vacuum sublimation and other similar procedures,
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the sterile plasma can be placed in t he container from
which it is ultimately to be dispensed, and attached to
the manifold of the vacuum apparatus, or, after loose
plugg ing, placed within the apparatus.

In this way

sepsis, as a result of multiple transf er, is avoided,
and in the former procedure t h e container may be sealed
in vacu o at the completion of the process before removal
from the manifold.

The dry product has a porous struc-

ture of considerable bulk and surface wh ich readily
goes into solution upon admission of a suitab~e quantity
of sterile distilled water int o the container.

For this

purpose, and to facilitate dispensation, various types
of vac c ine bottle stoppers have been employed, connection to the vacuum apparatus may be made through these,
or by glass side-arms which are sealed off separately
with a blow torch.

(138)

Any method of desiccation must adhere to certain
general principles: {139)
1. Te92.erature control.

To avoid denaturation of

the p la sma proteins, desiccation must be carried out at
low temp erature, if possible below O deg.
case above 37 deg.
2. Solubilitz.

c.,

and in no

c.
The desiccated product must be
-61-

readily and completely soluble in distilled water.

Tb.is

characteristic appears to be definitely related to the
temperature during the drying process, plasm.a desiccated from the frozen state being porous and readily soluble.
3. Sterilit~ . Dried plasma must b e absolutely sterile.
Tb.is is achieved eit her by obtaining plasma from blood
under sterile conditions, or sterilization by filtration
before desiccation.

Desiccation must be done in a manner

to preserve sterility, and the dried product is preferably
sealed in the vessel in wh ich it was desiccated.
4. Rapidity.

Desiccation sh ould be carried out as

rapidly as possible.

This is particularly important when

large volumes are to be processed.
5. Econo.!!!Z•

It is highly desirable that desiccation

be done with a minimum of labor, attention and expense.
The rate at which plasma can be de s iccated by vacuum
sublimation procedures is largely a function of the size
of the apparatus.

When large volumes are to be prepared

and stored for use in the treatment of casualties, civilian as well as military, incidental to warfare, this is
probably done most efficiently by means of the large scale
apparatus employed in the Desivac process.

Such an appara-

tus suitable for the dehydration of 600 liters of plasma
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per week is now available. (140)

The moisture content

of the final product of these various processes is
usually .3% and may be reduced to a mere trace. Preservation in the dried state is generally not accepted as
being satisfactory unless the residual moisture is less
than 1%. (141)
(a) Restoration and administration of dried plasma.
Restoration of dried plasma is done with pyrogenfree distilled water.

This is easily done, without

delay or danger of contamination, with any type of vacuum bottle, such as Centrivac or Plasmavac, containing
the dried product, and another container with the pyrogen-free distilled water in it.

The rubber caps, wh ich

protect the rubber stoppers in the tops of each container,
are removed from both, and the stoppers are cleansed with
70

%alcohol.

A

length of rubber tubing with a screw

clamp and intravenous needles at either end, is usual l y
provided in a sterile glass tube.

The needle at one end

of the tubing is inserted into the top of the distilled
water bottle, and then after closing t he screw clamp,
the needle at the other end is inserted i nto the vacuum
bottle containing the dried plasma.

By opening the screw

clamp t h e vacuum allows for the flow of distilled water
from one bottle into the oth er containing the dried
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plasma.

For administration the reconstituted plasma

is then placed in an inverted position in a sling, and
the intravenous needle which was used to puncture the
distilled water bottle stopper, is utilized for venipuncture, regulating the flow by means of the screw
clamp.
{b) Advantages and disadvantages of dried . plasma.
(142)

The advantages of dried plasma over frozen plasma
are that:
1. It can be preserved and transported under all
conditions of temperature without refrigerants.
2. It can be regenerated for admi nis tration in a

short period of time--2 to 5 minutes against
20 minutes to thaw frozen plasma-- under adverse
conditions.
3. If indicated, it lends itself to administration
in a concentrated form.
Disadvantages of dried plasma are:

1. Proper drying of plasma at best is a difficult
and expensive procedure.
2. It is not readily adaptable for use in the

average hospital, but requires a cooperative
plan whereby dried plasma is prepared in institutions provided with larger apparatus and properly trained personnel.
-64-

Effects on plasma of preservation in various forms.
{a) Effect on the safety of plasma.
In considering the value of any therapeutic agent,
first consideration must be given to the possibility of
harmful effects on the patient.

Pooled or diluted human

plasma, separated with ordinary aseptic precautions from
citrated blood immediately after collection, and administered at once to the patient , has proven to be free
of reactions save for mild urticarial manifestations .
(143)

This strictly fresh plasma is an ideal blood sub-

stitute, but its routine use is not practicable, as
plasma to serve all its purposes, must be available in
a form not requiring time-consuming preparation before
administration.
In any method of preservation u s ed, the safety of
the material may be affected by; (1) the comparative
ease of bacterial contamination, and (2) the tendency
of certain unstable proteins to form particles.

Bac-

terial contamination has been responsible for most of
the febrile reactions which have been reported, and has
been the most serious obstacle to the preservation of
plasma in the liquid state.

(144) (145)

Mayner's

report, (146) of a sudden death during intravenous
administration of unfiltered plasma , emphasizes the
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absolute necessity of -- strict care in the prevention
of flocculation;
already formed.

and of filtration to remove floculi
If administered, such flocculi form

emboli of fibrin-like material blocking numerous small
branches of the pulmonary artery within the lung tissue.
Both bacterial contamination and flocculation may
be effectively prevented by rapid separation of plasma
from the freshly collected blood, followed by prompt
fixation of plasma by freezing.

Plasma then may be

stored in the frozen state, or if desired, dried from
the frozen state.

Proper restoration from the frozen

state, as described under that heading, results in a
liquid free from flocculi, and practically indistinguishable from the original material except that it is
turbid.

This turbidity, however, apparently does not

cause untoward effects. (147)
Novak, (148) feels that bacterial contamination is
the only important problem involved in the storage of
fluid plasma, and that the use of sulfonamide derivatives makes it possible to rely on the safety and immediate availability of stored liquid plasma.

Strumia and

McGraw, (149) feel that in order to insure a safe material
aside from bacterial contamination and flocculation,
provision must be made to reduce an occasionally high
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isoagglutinin content, by pooling from 8 to 12 lots
of plasma.
{b) Effect on certain specific elements of plasma.
Plasma that has been properly preserved by freezing, and thawed rapidly, is the only method of preservation which maintains the maximal content of all the
specific elements of plasma. (150)

The amount of pro-

tein lost by flocculation occurring in liquid plasma
preserved at 4 deg.

c.

is practically negligible, and

flocculation is almost completely eliminated by preservation of plasma at room temperature.

Desiccation of

plasma apparently alters the albumin-globulin ratio
as determined by the usual laboratory methods, but no
indication of alteration of the proteins is found in
the cataphoretic pattern obtained by the Tiselius
apparatus. (151)
The specific antibodies contained in plasma are
relatively stable, but complement content is considerably influenced by the method of preservation.

The

preservation of complement is optimal when the plasma
is maintained in the frozen state, very satisfactory
for almost two months when it is maintained at 4 deg.

c.,

fair when preserved by drying, and poor when

maintained at room temperature.
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It 1s possible , but

less practicable, to dry plasma in such a manner as to
maintain a higher content of complement. (152)
The loss of prothrombin in citrated blood kept at
4 deg.

c.,

has b een reported by Rhoads, et al, (153)

and Lord and Pastore~ (154)

The preservation of pro-

thrombin in liquid plasma at 4 deg.
that reported for whole blood.

c.

is better than

The optimal method for

the preservation of prothrombin is again maintenance in
the frozen state.

Plasma dried from the frozen state

and restored with sterile pyrogen-free distilled water,
or plasma stored at room temperature, shows almost
complete loss of prothrombin.

Strumia, (155) rep orts

in a current publication, however, that he and his coworkers have about half completed studies which will
result in the solution of the problem of the disadvantage of loss of prothrombin content of dried plasma.
He feels, as do Flosdorf and Mudd, (156) that the loss
of prothrombin in the dried plasma is connected with
the greatly increased alkalinity of this product due
to, (l) addition of sodium citrate to prevent coagulation of the whol e blood, and (2) loss of serums
duri ng the drying p eriod due to the h igh vacuum.

He

has found that by buffering the citrate solution, or
by regeneration of the plasma in sterile water saturated with carbon dioxide, that a remarkable preservation
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of prothrombin is obtained.
To summarize briefly then, regardless of the means
of preservation employed, plasma must be safe from the
standpoint of, (l} bacterial contamination, (2} presence
of flocculent protein precipitates, and (3) unusually
high isoagglutinin titer.

The manner of preservation

greatly influences the survival of various specific
elements of plasma;
1. Preservation at room temperature of plasma in
the liquid state causes little flocculation, but rapid
loss of prothrombin and complement .

The value of such

plasma is limited entirely. to its total protein content.
2. Preservation -of plasma in the liquid form at
4 deg.

c.

maintains a fair quantity of prothrombin and

complement for a period of about 50 days, but causes
maximal flocculation within a few hours .

Filtration

of such a product is essential, and the problem of
bacterial contamination must be dealt with.
3. Preservation of plasma in the dried state will
effectively prevent bact erial growth and flocculation,
but the regenerated material has lost almost all of its
prothrombin and a portion of the complement.

Thus this

product is of little value for hypoprothrombinemic therapy.
4. Preservation in the frozen state prevents
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bacterial growth and flocculation, and at the same time
insures almost complete preservation of all specific
elements, including prothrombin and complement.

After

properly thawing the frozen plasma, its therapeutic
value is practically equal to that of freshly prepared
plasma.
5. Preservation in the liquid state may become
more practicable, should Novak's work on prevention
of contamination by use of sodium sulfathiazole, be
confirmed by other workers.

Tb.is, however, will not

obviate the flocculation problem and such p lasma nn.ist
be properly filt~red prior to use, a procedure usually
not nece s sary with frozen plasma.

-?o-

VI-THERAPEUTIC INDICATIONS FOR BLOOD PLASMA AND SERUM.
A- Traumatic shock, including a discussion of the
physiology of the plasma proteins.
An intelligent conception of t h e physiology of

the plasma proteins is essential for an adequate understanding of all phases and types of shock, and the
effective administration of human plasma in the treatment of the many disorders in which it has proven to
be a specific.

It is therefore fitting that considera-

tion be given to the part that plasma proteins play in
the maintenance of the proper fluid balance and normal
circulatory efficiency of the body.
In the process of gastro-intestinal digestion, the
protein foods are split into the elemental substances-the amino acids-- and are absorbed as such in the lower
part of the small intestine.

These amino acids are

carried by the blood to the liver where some of them
are utilized in the formation of the plasma proteins.
(157)

It is fairly well agreed that a large part of

the fibrinogen, practically all of the albumin fraction,
and at least a part of the globulin, are produced by
that organ.

Not only are these plasma proteins very

largely manufactured there, but also a considerable
quantity of the proteins thus formed, are stored in
the liver, and held there as a reserve supply for the
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body to be used as the need arises.

It is the opinion

of Madden and Whipple, (158) that the protein is held
in the liver cells as a part of the cell cytoplasm,and
not deposited as a specialized substance in the way in
which glycogen is stored.

For the greater part, the

tissue cells construct their own particular proteins
from the amino acids circulating in the blood stream
subsequent to digestion and absorption of food. (159)
Under certain circums tances, however, the body cells
are capable of utilizing the plasma proteins for that
purpose, as proven by the fact that an animal can be
kept alive indefinitely in a state of c omplete nitrogen
balance by the intravenous injection of b~ood plasma~ ~{re.'<
while it is being kept on a pro t einj iet. (160)

___ '"_,)

The plasma proteins are very complex substances
and consist of molecules whi ch are quite large, some
of them having a molecular weight of as high as 35,000
to 192,000.

Because of the great size of its molecules,

it is practically impossible, normally, for such a
substance to pass through a semipermeable membrane as
that comprising the capillary walls.

It is also thought

that the plasma proteins are more or less loosely joined
together, forming a fluid mass quite comparable to the
cytoplasm of a cell body. (161)
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This fact would make

,?

· it even less capable of pas s ing through the vascular
walls into the interstitial spaces.

Because of this

almost complete lack of ability to permeate the normal
capillary wall, the plasma proteins are quite effectively retained within the vascular lumen.

By their pres-

ence here they assist in the proper distribution of
water, electrolytes and the other crystalloids, and
aid in the process of the interchange of these materials
between the intra and extra-vascular spaces and the cell
bodies. ( 162)

CAPILLARIES
B.p. l2 mm. Hg.
li::t'rect1~e Osmot1c P~es
27 l?trn. Iig .

Water, crystalloids
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Water, electrolytes,
Protein

Hydrostatic press. 8 mm. Hg!Hydrostatic press. 8 mm. Hg.
I
I

Filtration Pre!sure 7 mm. Hg.

'
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(Fig. 1)
This interchange is brought about by two physical
forces.

Blood at a certain point in the capillary has

a pressure, let us as sume, of 30 mm. Hg.

This is the

force which drives the water and its dissolved crystalloids through the capillary membrane.

This pressure is

offset, in part, by hydrostatic pressure of the tissue
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fluids on the outer side of the capillary membrane.
Tb.e latter pressure is less than that in the capillaries, and for purposes of illustration, can be
assumed to be 8 mm. Hg.

The effective hydrostatic

pressure is thus 22 mm. Hg.

In addition, the osmotic

pressure, produced by the plasma proteins, must be
taken into account.
about 25 rmn. Hg.

In the plasma this amounts to

The tissue fluids contain smaller

amounts of proteins and thus have only about 10 nnn.

Hg. in osmotic force.

The difference, 15 mm. Hg.,

acts as an attractive force to hold fluid within the
vessels, and so will detract from the effective hydrostatic pressure of 22 mm. Hg., leaving a net filtration
pressure of 7 mm. Hg.
The loss of_ fluid from the ves s el lumen as the
blood traverses the capillary to the venous end,
produces a decrease in the hydrost atic pres sure in
the latter region, to about 12 mm. Hg.

Coincidenta~ly

the concentration of the colloid, produced by the loss
of fluid, causes the plasma osmotic force to rise to
an effective osmotic pressure of about 27 mm. Hg.
The interstitial hydrostatic pressure remains the
same, namely 8 mm. Hg.

Thus there is produced a positive
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osmotic attraction equal to 7 mm. Hg., which satisfactorily effects the re-entry into the capillary of approximately the same quantity of fluid as was lost
from the arterial side.

I n this ma nner blood volume

is maintained and the interchange of body fluids is
accomplished. (163)
In view of these facts, one may postulate, assuming a normal electrolytic balance and a full degree of

cardiac compensation, that the presence of a normal
concentration of plasma protein in the intravascular
spaces assures a n or mal blood volume and a satisfactory
cardiac output.

Under the same circumstances, the

normal plasma protein concentration in the vessels,
provides a normal amount of extravascular fluid in
the interstices and in the lymph spaces.

It is ob-

vious, on the other hand, that a decrease in the concentration of the plasma protein in the intravascular
space from any cause, wil l result in two deviations
from the normal.

The greater differential between

the blood pressure and the sum of the colloid pressure
and the interstitial pressure, results in the filtration of a larger quantity of water, with its soluble
substances, into the extravascular spaces.

At the

other end of the capillary, because of the low plasma
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protein, the colloid pressure does not increase
sufficiently to effect the re-entry of an equal
amount of this fluid.

Thus there is produced an

accumulation of an excess of interstitial fluid.
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DISTURBED FILTRATION WITH LOW PLASWlA PROTEIN
(Fig. 2)
With the above facts in mind let us then turn to
traumatic shock and the circulatory deficiency found in
that state .

In accordance with the theory of Moon, (164-5)

at the site of and as a result of the injury, there is
produced a toxic substance which is capable of, and does
produce, a widespread and geperal dilatation of the capillaries, and an increased permeability of their walls,
not only to the other constituents of plasma, but to
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the plasma protein as well.

The degree of capillary

dilatation and increased permeability is approximately
proportiona t e to the amount of the toxic substance liberated.

While this paper is not concerned with the

pathogenesis of shock, except as it relates to treatment with plasma, it may not be amiss to state, it is
generally agreed, that t h ere is a decrease in the effective vo l ume of circulating blood due to a decrease in the
blood volume-- los s into the tissues or to the outside-or to an increase in the capacity of the vascular system,
or to both.

The mechanism of the reduction in blood

volume is not entirely understood, but is, for the most
part, a result of obvious and concealed bleeding at the
site of injury, and excessive loss of plasma in the traumatized tis sues, in the cases of trauma.tic shock and burns.
(166) (167) (168)

Subsequent to the decrea s e in blood

volume, cardiac output is decreased , arteriolar constriction occurs (vasodilatation in primary shock), the blood
pressur e is reduced, capillary stas i s develops, and cell
anoxia is produced, followed by the production of toxic
substances.

(169)

As a result of these toxic substances

the capillaries throughout the body are dilated and their
walls made permeable to all the elements of blood plasma
including the plasma proteins.

As this proces s progresses

the blood volume is further reduced, capillary sta s is is
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augmented, circulatory failure develops, and the death
of the patient supervenes. (170)

It must be emphasized

that, after diminution of the circulating blood volume
and blood pressure, and the resulting anoxia have exerted their ill effe c ts, the alterations may become
irreversible and no known therapy will result in recovery. (171)
True shock is seen in the fol l owing conditions:
(172)

1. Hemorrhage. T:his is the most typical cause of
shock.

Loss of 1000 cc. of blood in the average indi-

vidual will be followed by a state of shock.
2. Operation. Tiie blood loss in surgical procedures is much greater than is generally appreciated.
T:he Ma.yo Clinic has shown, by gathering and washing
out the discarded blood-soaked sponges following operations, and analyzing the resulting fluid for hemoglobin content, that from 500 to 2000 cc. of blood may be
lost under various conditions of operation.
3.

Anesthesia.

Prolonged anesthetic state causes

true shock by producing vascular dilatation, particularly of the splanchnic area, with a corresponding pooling
of blood, which is then lost to the general circulation.
4. Wounds.

Shock develops following wounds either

because of hemorrhage externally, or because of the loss
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of fluid elements of blood into the tissues .
5. Burns.

Whenever superficial layers of the skin

are destroyed so that the capillary bed is dam.aged, there
is extensive loss of fluid externally, as well as a state
of fluid imbalance internally, with resultant increase
in tissue fluids and decrease in plasma volume.
With the above facts in mind , the mechanism underlying traumatic shock can readily be comprehended.

The

injury to the tissue cells brings about the ~roduction
of effective quantities of a toxic substance.

Tb.is

factor acts upon the capillaries locally at the site
of trauma, and generally throughout the body, bringing
about their dilatation and an increase in their permeability to all the constituents of blood plasma.

With

profuse transudation and exudation of water , electrolytes and plasma proteins, the blood volume is materially
decreased and hemoconcentration occurs.

The hemoconcentra-

tion, the increased viscosity of the blood, the decreased
blood pressure, and the circulatory stasis, as it occurs
in the dilated capillaries, result in cell anoxia.

It

has been proven that cell anoxia itself is capable of,
and does initiate, the production of the toxic substance.
(173)

Trius, there is added a second factor which con-

tributes to the greater dilatation of the capillaries,
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THE MECHANISM OF SHOCK
WITH ITS IRREVERSIBLE PHASE • .

(Fig. 3)
and a more widespread and profuse loss of the intravascular fluid.

This results in the further decrease

in blood volume and a more marked hemoconcentration.
In this way a vicious circle is instituted with the

-so-

establishment of irreversible shock.

Eventually the

peripheral arteriolar constriction fails to compensate
for the increased loss of blood volume, the vital centers suffer from anoxia, circulation fails completely,
and death follows.
In view of the above premises, it appears obvious
that the ideal therapeutic agent, in treating such conditions, would be one which enabled the attending physician to increase rapidly and permanently the patient's
blood volume.

T:he transfusion of whole blood has been

the best answer to this problem in the past.

Blood

substitutes, other than plasma, used for the treatment
of secondary shock have so far generally failed.

Physio-

logical solutions of sodium chloride and dextrose, which
are readily available, do not produce a permanent increase in the circulating blood volume, as in the majority of cases, they rapidly leave the circulation. (174)
The use of acacia solutions as a blood substitute, while
more effective than physiological saline in maintaining
circulating blood volume, (175) (176) (177), is often
followed by severe reactions. (178)

On close analysis

whole blood itself is not the ideal agent for this condition.

There are two essential drawbacks in using

whole blood which have been emphasized by li'la.honey: (179)
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(a) the relatively long interval of time necessary to
make whol e blood available for transfusion, and (b) the
undesirable addition of red blood cells to the already
concentrated blood, (the latter is especially evident
in burn shock).
These facts make it apparent that the physiologic
approach to the tre a tment of traumatic shock is the
replacement of plasma protein, best done by the transfusion of adequate amounts of blood plasma..

This will

replace proteins, restore fluid balance, increase the
blood volwne and cardiac output, relieve tissue anoxia,
and prevent circulatory failure.

Therapy inadequately

administered, or treatment begun after irreversible
shock has developed, is almost certain to be of no
avail.

Restoration of circulating blood volume is the

essential aim of the treatment of shock, regardless of
its cause, whether hematogenic, neurogenic, vasogenic,
or strictly post-hemorrhagic.

'I'he part played by these

causative factors is highly controversal and need not
be considered here.

There is, however, as above stated,

general agreement with regard to the general mechanism
of shock, namely the disparity in b l ood volume relative
to vascular capacity.
White, (180) in an analysis of 50 cases of shock
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treated with plasma transfusion, state that there was
unanimity of opinion that the best remedy for shock,
when all considerations were weighed, was undiluted
plasma or saline-plasma.

In some instances, notably

in the presence of hemorrhage, whole blood was undoubtadly the best antidote.

However, when time was an

element, or if a reaction would add to the gravity of
the situation, whole blood suffers by comparison with
plasma.

T:hese workers state that they have had no

experience with concentrated plasma.

Hill and his co-

workers, (181) state that concentrated plasma appears
to be ideal for this purpose--shock-- for several
reasons; (1) larger amounts of protein can be more
speedily placed in the circulation than by any other
method.

This is a point of importance in view of

Minot and Blalock's, (182) suggestion of the value of
giving colloid fast enough to increase the level to
the point of reta i ning effective circulating volume
in spite of concomitant losses.

(2) Hypertonic plasma

tends to effect an immediate reversal of the abnormal
physiologic changes of shock.

Blood volume is built

up by immediate withdrawal from tissues of fluid previously lost from the blood stream.

As stated by

Blalock, (183) a given quantity of plasma causes a
greater increase in osmotic pressure than an equal
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quantity of blood.

(3) Concentrated plasma probably

has a direct stimulating effect on vascular tone and
permeability.

(4) Four times concentrated plasma can

be administered by the simple expedient of a 50 or 100
cc. syringe with an attached 19 or 20 gauge needle, and
can be given at rates up to 100 cc.per minute as indicated.

The work of Krogh and Harrop, (184) demonstrated

the importance of plasma proteins, or associated substances, in the maintenance of capillary tone and normal
permeability.

The evidence suggested that the concentra-

tion of these substances was a favorable factor.

Hill

and his co-workers, (foregoing) treated 45 cases of
shock with concentrated plasma, and obtained in general,
an almost invariable innnediate marked and sustained increase in blood pressure .

They attribute the speed of

response partly to direct stimulation of the vascular
tree, and partly to an increase in blood volume.

The

latter is due to withdrawal of tissue fluid into the
circulation, and not merely to the added volume of
concentrated plasma.

This is shown by, (a) a decrease

of whole blood specific gravity, although the specific
gravity of the added concentrated plasma was much greater that that of whole blood, (b) relatively little
change in the specific gravity of the patient's plasma,
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(occasionally a decrease) and (c) the extent of change
in plasma volume, as shown by hema.tocrit or hemoglobin,
being out of proportion to the amount of plasma given.
Brennan, .(185) points out that in shock the red cells
apparently take up water, increasing in size as much
as 50%, and that large numbers of them become sidetracked in the muscle capillaries out of circulation.
Considering this, hypertonic plasma should be superior
to whole plasma in reducing erythrocyte size by water
shift.
Mahoney, Kingsley and Howland, (186) however,
present contradictory evidence to the above.

In the

results of their observations on the effect of treatment of experimentally produced shock in dogs, by
injections of, (a) dilute, (b) normal, and (c) concentrated plasma they state, "whole plasma or dilute
plasma are both more efficient than concentrated plasma
in the prophylactic or therapeutic management of experimental peripheral circulatory failure

11

•

They

were able to prevent the development of shock by the
intravenous injection of large volumes of one-half
dilution of plasma.

They emphasize the hazard of com-

paring experimental results with conditions which occur
in clinical practice, as the type of shock studied in
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the laboratory is severe, and very large amounts of
plasma are required to be effective.

The results of

their experiments do show, however, that with the peripheral circulatory failure of shock the reclamation
of extravascular fluid by the u s e of concentrated
plasma injections is not sound.

Fluid must be made

available by parenteral injection, or concentrated
plasma will only add to the already increased viscosity of the blood. 1hus on an experimental basis, at
least, one should use either whole plasma or one-half
diluted plasma instead of the concentrated form,in the
treatment of traumatic shock.
Tisdal, {187) states that "plasma is peculiarly
adapted for obstetric needs", indicating that obstetric
shock and hemorrhage require immediate and adequate
replacement of blood volume by means of blood plasma
transfusions.

Mathews, (188) reports that plasma is

ideal for cases of shock in air-raid casualties in
England, producing very great clinical improvement and
rise of blood pressure in a few minutes.
11

He states,

it has become standard practice to use plasma for

intravenous therapy in severely shocked air raid victims.
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As regards dosage, Strumia and McGraw, (189)
state that the amount of plasma usually administered
is smaller than the quantity necessary for best results .

In referring to the dosage of plasma, it is far

better to speak of the grams of protein contained in
each dose, rather than the total amount of fluid employed.

This is desirable since there is a rather

wide variation in the amount of sodium citrate and
other solutions added to the whole blood at time of
collection, with a resultant variation in the dilution
of the plasma prepared from this blood.
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In cases of shock, with or without hemorrhage, the
usual initial dose of plasma is 35 to 36 grams of plasma
protein, corresponding to 500 cc. of undiluted plasma.
Additional doses may be re quired up to two or three
times this quantity.

The dose for any patient, of

course, is the amount needed to raise and maintain an
adequate volume of circulating blood as evidenced by
satisfactory pulse, blood pres sure, and blood concentration readings.
B. Hemorrhage.
The relation of shock to hemorrhage has been much
disputed, but traumatic shock and the symptoms of hemorrhage may both be produced by the loss of large quantities of blood. {190)

Hematogenic shock is typical

traumatic shock in which the important change is the
reduced blood volume, and it may occur as an aftermath
of severe hemorrhage.

It should be emphasized, however,

that the mechanism of the two conditions varies.

In

hematogenic shock there is a concentration of blood,
oligemia, by reason of reduction of blood volume
thro~gh plasma loss into the tissues. (191)

In shock

consequent upon hemorrhage, there is a dilution of
blood by transfer of fluid from the tissues to the
vessels.

This is a generally accepted fact and is
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supported by Brennan, (192) who was able to demonstrate this dilution by taking serial blood counts
every few minutes in cases of hemorrhage.

The di-

lut i on fluids, lacking as they do the specific plasma
proteins, and some, at least, of the normal inorganic
constituents of plasma, have a lower osmotic pressure
than nor mal plasma and therefore lower than that of
the corpuscles.

Consequently much of this fluid

passes into the corpuscles wh ich i ncreases their size.
Partly because of the mechanical effect of the swollen
corpuscles, and partly bec ause of the lowered blood
pressure, the blood stream, through the capillaries,
is first slowed, and later in many of them actually
stops.

Ti-tis is because the intravascular pressure is

not sufficient to keep it in motion.

Tile body will

_,,.ta
-but beyond that point the circulation is compr&nised

compensate for losses of blood up to about 750 cc.,

and symptoms appear.

If the blood volume continues

to diminish, the blood pressure declines in s pite of
vasoconstriction. (193)

If the hemorrhage is not too

severe, the situation takes care of itself by peripheral arteriolar constriction, however, if the hemorrhage should be massive the constriction of the
arterioles does not fully compensate for the blood
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loss, the peripheral circulation becomes inade quate,
and tissue anoxia occurs. (194)

In proportion to the

degree of anoxemia there will develop a production of
toxic substances, a dilatation and increased permeability of the capillaries, resulting in profuse and
widespread loss of plasma protein, and other plasma
constituents.

A most important point is the fact that,

although the actual hemorrhage may have been stopped,
the loss of blood volume continues as a result of the
initiated shock factors. (195)
The physiological approach to the proper therapy
of acute massive hemorrhage, is the transfusion of a
sufficient quantity of whole blood to replace approximately the amount of blood lost at the time of the hemorrhage.

Tb.is of course, presupposes careful typing

and accurate cross-matching of blood from the recipient
and the several donors, from whom the supply of blood
for transfusion is to be obtained.

On the other hand,

although t h e precipitating cause of t his t yp e of shock
is the loss of whole blood, the more important consideration in most cases of hemorrhage, is the decrease in
blood volume and not the loss of red cells. (196)

In

cases of severe hemorrhage the loss of erythrocytes is
a relatively secondary factor, one which contributes
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but little to the state of shock, provided the volume
of circulating blood is maintained at the proper level.
The practical use of plasma has shown its efficiency in
rapid restoration of proper circulation in cases of most
severe involvement, even those accompanied by a very
large loss of blood.

By using plasma. it is possible to

avoid altogether the emergency blood transfusion, with
its unavoidable serious delays, the dangers due to hurried preparation, and rapid administration.

Strumia, (197)

suggests the routine administration to all patients with
severe injuries, regardless of loss of blood, sufficient
plasma to secure recovery from shock, or if shock is not
present, to prevent its occurrence.

Later on when blood

dilution has taken place , the actual degree of anemia
can be estimated, and transfusion of whole blood resorted to if considered essential for recovery, or as more
commonly occurs, if it will shorten the period of convalescence.
As Blalock, (198) has shown, the transfusion of even
greater amounts of blood than that lost by hemorrhage may
not restore adequate circulation, particularly when the
shock is severe and prolonged.

Hill and his co-workers,

(199) indicate that in clinical cases of this type, that
hypertonic plasma, by immediately accelerating the circu-90-

lation, may yield beneficial results where whole blood
alone might fail.

They emphasize the stinmlation seems

to depend upon the concentration of the plasma, and the
speed of administration made possible only by hypertonic
(4 X concentrated} plasma, and reconnne:'d that even when
unlimited quantities of blood are available, hypertonic
plasma be given.

These workers have, over a period of

one and one-half years, given some 22,220 cc. of concentrated plasma to 156 hospital patients, and 8,295 cc.
to an undetermined number of outside patients, a total
of 30,515 cc. of plasma requiring over a quarter million
cubic centimeters of blood for its preparation.

The

dosage of concentrated plasma is somewhat higher than
are elsewhere recommended for whole plasma .
that,

11

T:b.ey state

in shock the aim should be to supply at least 40%

of the blood volume lost.

This might require from 200

to 300 cc. for the average adult in deep shock.

In

actual use as little as 100 cc. usually suffices and may
be repeated as required.

Since speed is important it is

advisable in profound shock, to give larger initial
amounts of 150 to 200 cc.".

A very low percentage of

transfusion reactions was noted in their cases.

They

concluded that when hemorrhage was a large, or even a
dominant factor in shock, concentrated plasma was so
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effective and rapid in action, that it was used not
merely as a blood substitute, but as a definite addition and improvement to the use of whole blood.
Black and Smith, (200) however, state that in
hemorrhage suf ficient to decrease the hemog lobin below 50%, plasma transfusion may actually be contraindicated.

In such cases they found that,

11

the gen-

eral condition of the patients was adversely affected
by the administration of plasma".

In their opinion

the ill effects of plasma was due to forced dilution
of the blood in excess of the limits within which
blood dilution is favorable to recovery from hemorrhage.
Whitby, (201) has treated over 100 air-raid casualties, using 165 pints of plasma which had been
stored at room temperature for from 10 to 56 days. He
states that, "in a complete and systematic study of
these cases, the ef fici ency of citrated plasma, when
used for reas onable quantitative replacement of blood
loss, has been unequivocal 11 •

He emphasizes the almost

unbelieveable amount of blo@a. loss some of the casualties suffered, the quantitative recovery of blood pressure as blood volume was restored, and the necessity for
restoring the protein level up to not less than 50% of
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blood loss.

Magladery, Solandt, and Best, (202) found

in their experiments that a 40% replacement of protein
was necessary.
Buttle and his co-workers, (203) studied the effects of various fluids in the treatment of acute hemorrhage, and found that plasma was the only blood substitute whose value consistently approximated that of
whole blood in the treatment of hemorrhage.

The remain-

ing substitutes gave inferior results.
Brennan, (204) made two very interesting observations in his study of material derived from 130 neurosurgical, and 56 general surgical cases:

(a) As a re-

sult of hemorrhage the individual red blood corpuscles
increase in size often by 30 to 50% or even more. (b)
Following hemorrhage, a considerable number of the patients red blood corpuscles, as h igh as 20% of the
number originally circulating, become sidetracked within the body, probably within the muscle capillaries.
Tb.ese practical observations s

~·

est obvious therapeu-

tic measures aimed at restoring these corpuscles to the

circulation.

In his work he found that this could best

be done by the use of plasma transfusion.
Gradwohl, (205) contrasts the indications for whole
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blood transfusion, and plasma transfusion, in shock
and hemorrhage, as follows:
1. In secondary shock without hemorrhage, use
plasma.
2. In secondary shock with hemorrhage, use plasma
for the immediate emergency, follow by early
blood transfusion.
3. In hemorrhage, (loss of both cells and plasma),
use whole blood, or plasma until blood can be
obtained.
Strumia and McGraw, (206) concur on the above.
Thus in the treatment of shock following hemorrhage,
plasma or serum transfusions are as efficacious in restoring fluid balance as the transfusion of whole blood.
However, it must not be overlooked that where the loss
of erythrocytes is an outstanding factor in the clinical
picture, whole blood transfusions are necessary.

After

blood volume has been restored by transfusion of plasma,
following hemorrhage, there exists an adequate quantity
of the fluid elements of the blood, but a marked decrease
in the number of red blood cells.

One difference in the

plasma-treated patient, however, is the fact that temporarily, at least, the red cells are of normal character
and capable of complete functional activity.
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In most

cases of severe hemorrhage and anemia, on the other
hand, the cells are of abnormal shape, size, and hemoglobin content, and are therefore incapable of carrying on their normal functions.

Another difference

which may be used against one's paralleling the two
conditions, is the rapidity of development of the
anemic state following hemorrhage, as compared to its
slow inception in anemia produced by other causes.
Practically this latter point apparently does not
cause an appreciable difference in the effectiveness
of plasma transfusion in hemorrhage .

The time saved

when plasma is employed, over that which must be consumed in preparing for the transfusion of whole blood,
is another factor of prime importance.

To type, and

then cross-match, consumes at least 30 to 40 minutes-time which can not well be afforded under the circumstances of an acute emergency.

The prompt and effici-

ent treatment by plasma transfusion would, no doubt,
prove life saving for at least the more critical cases
in which time is an important factor.
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c.

Burns.
In cases of s~ock associated with burns, the char-

acter of the shock is identical, in all respects, with
the usual features of clinical shock. The decreased
blood volume, the diminished cardiac output, the hemoconcentration, and the subsequent circulatory failure,
all manifest themselves in the manner previously described under shock.

It has long been known that a decrease

in the fluid fraction of the blood, variously described
as anhydremia, oligemia, or hemoconcentration, is a
common phenomena associated with severe burns. (207)
Elkinton, Wolff, and Lee, (208) in their experimental and clinical studies have done much to clarify
the mechanism of thi s hemoconcentration.

Davidson, (209)

studied the plasma proteins in ten cas es of burns, and
found a moderate lowering of the protein concentration
in the plasma, which in the presence of hemoconcentration,
was evidence of loss of whole plasma..

Blalock, (210) and

Beard, (211) in an experimental study in 1931, found
that the edema fluid accumulating in the burned area
averaged 57% of the total plasma volume, and contained
about the same concentration of protein as plasma.
Mciver, {212) reported considerable data in a series of
extensive cutaneous burns, and noted that the blister
fluid was like plasma and contained 3.7% of total protein.
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He stated, therefore, that "the loss of fluid is not
simply a loss of water content of blood, but of a substance that is closely parallel to whole plasma".

In

the treatment of these patients, h owever, plasma was
not used, and he makes no mention of this form of therapy.
A large number of experimental studie s made on cutaneous
burns, covering the last decade, were sunnnarized by
Harkins and Harmon, (213) in 1937, all of which definitely demonstra ted that, following a severe burn there
is a tremendous los s into t h e burned area of a fluid
wh ich has a composition close to that of plasma.

Harkins,

(214) (215) working alone in 1935, reported demonstrating in dogs a considerable reduction in "bleeding volumen,
and hence in blo od volume, in experimental burns.

In

1936, in a report by Weiner, Rowlett er and Elman, (216)
data on 40 patients with severe burns tre a ted at the St.
Louis City Hospital was given.

A ver y def i nite relative

as well a s actual fall in t h e concentration of the serum
protein was observed.

The u s e of plasma transfusions

was advocated in t h is paper, and it was also pointed out
that too large amount of dextrose or saline solutions were
deleterious, in that edema might be provoked by their use.
These exper i mental and clinical observa tions indicate
the fundamental mechanism of the f l u id imbalance which
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occurs during the first few hours after a severe burn.
Cap illary stasis and altered permeability in the burned area all ow passage of plasma protein across the capillary membrane, with a corresponding disturbance of
osmotic pressure relationships.

As a result, tissue

fluids are increased, and the plasma volume is diminished.

T:his fluid imbalance is primarily an abnormal

distribution of fluid, rather than an external loss.
(217)

In addition to this abnormal distribution of

fluid, there is, before tanning, a c onsiderable loss
of plasma protein into the large bullae, and from the
raw surface of the burned area. (218)

Even then, this

amount is small in comparison to that which accumulates
in the tissues. (219)
This conception of the physiology involving plasma
proteins in severe burns, leads to certain logical deductions regarding therapy.

Cole and Elman, (220)

make the statement, "too much fluid may be deleterious
unless urinary excretion is adequate, because it is apt
to produce a general edema ••••• true replacement therapy,
therefore, should consist of intravenous injection of
blood plasma".

Lucido, (221) in reporting the metabolic

and blood chemical changes in a severe burn, notes that
a severely burned patient excretes large amounts of
nitrogen in the urine.

This evidence of excessive
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destruction of protein is an additional reason for the
administration of a large protein intake in the severely
burned patient.

It is clear that the fluid lost from

the vascular compartment to the tissues would best be
returned by replacing the lost plasma protein.

This

would raise the osmotic pressure of the plasma to a
value sufficient to restore and maintain the normal
distribution of fluid between the intravascular and
interstitial compartments.
Black, (222) reports that the period during which
patients with burns are in jeopardy from shock extends
some 48 or 72 hours after the incident.

He comments

that, in the absence of a direct method of improving
capillary tone, the object of treatment is to maintain
an ade quate blood volume, by replacing the protein and
fluid lost, in an effort to maintain the circulation
during this 48 to 72 hour danger period.

He also states

that translating into a clinical idiom, the indications
for plasma or serum transfusion, is made difficult by
the inconstant relation between the fal l in blood volume, (which is the fundamental indication for plasma or

serum therapy), and the usual clinical data such as blood
pressure and pulse rate.

For, while any fall in blood

pressure coupled with an increase in the pulse rate
above 100, is an indication for serum or plasma transfusion, certain cases may b e in the early stag es of pro-100-

gressive shock, yet show no alteration in blood pressure and no great chang es in the pulse rate.

In such

cases, by t h e time significant changes have occurred
in the blood pres sure, recovery may be impossible or
extremely large doses of plasma may be required; whereas, administered earlier, smaller doses would have been
sufficient.

Black therefore suggests, as a simple means

of study in s u ch c a ses, serial hemog lobin estimations as
a measure of hemoconcentration.

Moon, (223) has also

called attention to the importance of serial red cell
counts and their comparison wi th an erythrocyte count,
taken when the patient is first seen, and he has shown
the value of t h is procedure as a means to indicate the
presence and degree of hemoconcentration.
Black, (224) suggests using serial hemoglobin determinations as a means of calculating the plasma deficit-"For approximate calculation of the deficit in plasma
volume, one is justified in assuming a hemogl obin percentage of 100 and a blood volume of 5 liters, of which
3

liters is plasma.

The incre as ed hemoglobin value ob-

served bears t he same ratio to the initial value, as the
initial v a lue for blood volume does to the new blood volume, since the red cell volume remains unchanged.

This

may be expressed in the formula, Hb2: BV1 or substituting
BV2
Hb1
-101-

=

the assumed values, Hb2
~ where Hb 2 is the observ100
5 -X
ed hemoglobin value after the burn, and Xis the amount
of plasma lost.

X then can readily be calculated if Hb 2
He warns, however , that this fornru.la can only

is known."

be used in patients who were in good health before the
burn, and in whom the injury causing the burn, did not
also cause significant hemorrhage.

He also emphasizes

that to avoid overdosage, it is necessary to examine the
patient every few hours , even though the plasma deficit
has been calculated.
Tidy, (225) agrees with Black on the value of such
a formula for the calculation of the plasma deficit, but
notes that the assumption of a hemoglobin of 100% is not
necessarily justified.

He instead suggests the follow-

ing formula as an improvement on that of Black's, X:
5 (y -100) where y is the percentage of hemoglobin.
y
Bushby, Kekwick, and Schweitzer, (226) have also
presented a method for tre estimation of blood volume
in plasma transfusion, based upon the simple observations which can be carried out during the course of the
transfusion.

\'Vb.en a known volume of plasma is added to

an unknown volume of blood, the volume of red cells in
the circulation remains unchanged, if there is no hemorrhage.

Hence the red cells can be used as an indica-

tor of the amount of dilution brought about by transfu-102-

sion;

and providing the observations on the red cells

are carried out before and immediately after the rapid
transfusion of a known volume of plasma, the original
blood volume of the transfused subject can be determined
by a simple calculation.

If a patient with an unknown

blood volume, V, has an hematocrit and cell content of

X%

before transfusion, and after transfusion he has P

cc. of plasma, and an hematocrit reading of

y%; then

the relation of the unknown, V, to P, X and y, all of
which are known, is determined by simple inverse proportion-- V:(V+P) :: y:X.
Elkinton, Wolff, and Lee, (227) (228) (229) in an
effor to evaluate the efficacy of plasma therapy in
burns, devised still another method of calculating the
amount of fluid necessary.

During the phase of fluid

shift, hema.tocrit and plasma . protein determinations
were made every few hours.

From these figures approx-

imate plasma volumes, and total amounts of circulating
plasma protein were calculated.

The amount of plasma,

corresponding to a unit of cells at any hematocrit
value, was compared with the plasma corresponding to
the unit volume of cells at the normal hematocrit value,
in order to give a ratio of plasma volume changes. This
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ratio was expressed as follows:

(100 - Ho)Hn
(100 - Hn)ffcr

,

Hn stands for the normal hematocrit value, Ho for the

observed hematocrit value.

When the normal plasma vol-

ume, arbitrarily as sumed to equal 5% of the body weight,
is multiplied by this factor, an approximate value for
the observed plasma volume is obtained.

From this plasma

volume and the observed plasma protein concentration, the
total amount of circulating plasma protein is estimated.
The plasma deficit is the difference between the latter
value and the normal total amount of plasma protein-7 gm. per cent times the normal p lasma volume.

This cal-

culation of the plasma protein deficit may be expressed
in a single formula as follows:
W(lOO - Ho) Hn Po
3.5 W - 2 (lOO _ Hn) H0

- ~lasma protein deficit
in grms.

Normal body weight, (W)
Normal hematocrit, (Hn)
Normal plasma protein concentration, (Pn)
Observed hematocrit,(Ho)
The deficit, or requirement in grams of protein may be
converted into cubic centimeters of plasma by the use
of a factor, 14.

Plasma in cc. equals grams plasma pro-

tein multiplied by 14.

These workers estimate that the

calculated requirement should be within 10% of the real
value, since the calculation involves errors inherent
in the measurement of hematocrit and plasma protein
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values, and in the assumption of a normal hematocrit
level and plasma volume.
The main fallacy of all methods for the estimation of blood volume in exsanguinated patients, is
that hemorrhag e is continued while the test substances
are being injected.

Ideally, hemorrhage should always

have ceased. However, such errors do not place these
methods outside of the realm of usefullness and practical utility. (230)
The magnitude of the plasma loss in cases of severe burns is often v ery great, as shown by Elman,
(231) who sta tes that the loss is such that 10 cc. of
plasma, or 20 cc. of blood, per kilogram of body weight,
may have to be given and be repeated if neces s ary.

In

figures adjusted to whole blood, t hi s would mean, i n
the cases he cites, some 5,500 cc. g iven over a period
of 4 days.

Lam, (232) also calls a t tention to the fact

that the large amounts of plasma necessary in burns is
not generally appreciated.

Using t h e fornmla of Wolff,

Elkinton, and Lee, •g iven above, to estimate the amount
of pla sma needed, this worker rep ort s one case, with
burns involving 20% of the body surf ace, re quiring 2,000
cc. of plasma over a 12 hour period; and another patient
with burns involving 45% of the body surface, requiring
2,200 cc. of plasma over a 24 hour period.
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Strumia and

and McGraw, (233) state that the dosage of plasma in
burns, beyond the original shock period, is best determined by the plasma protein content of the circulating blood, by the urinary output, and by the occurrence
of edema.

They cite a patient, with severe burns ex-

tending over approximately two-thirds of the body surface, requiring 700 grams of plasma protein, the equivalent of 10 liters of plasma, or 40 lots of blood of
500 cc. each!
Elkinton, Wolff, and Lee, (234) bring out another
very i mportant point which must be taken into account
in the therapy of burn shock-- that massive plasma transfusions are not retained until the leaking capillaries
have had time to regain their normal permeability.
They present evidence to show that loss of plasma continues until the thirty first to the fortieth hour after
injury.

During this period, however, excessive hemocon-

centration can be prevented by small repeated transfusions of plasma.

After the fortieth hour, when the cap-

illaries have regained their impermeability to protein,
the deficit of plasma protein may be corrected quantitatively by a large plasma transfusion, the amount of protein required being calculated from the formula based on
hernatocrit values, plasma concentration of protein, and
body weight.

Such a regime permits the restoration of

plasma volume to normal without the administration of
excessive amounts of protein-free fluids.
-106-

I

~I

iTaun.4

~urn

I

Toxic
substance_

: _.

Cell
anoxia

Iner. cap.
permeability

eapillary
stasis

Decreased
blood volume

Lowered
blood pressure

~
Decreased
- - - - - - - ~ cardiac ?utput

I

Gire. failure,
death

THE.§_HOCK OF BURNS,
IRREVERSIBLE PHASE.
ig.

~

..

~j

I Subrt~
Toxic

Plasma
transfusion

Iner. cap.
permeability

l

Decreased
blood volume
,,,..

/

.

Adequate
tissue oxygen

,

Satisfactory
periph.· circ.

Restored
blood volume

Maintained
blood pressure

Adequate
cardiac output

TREATMENT OF SHOCK
OF BURNS.
(Fig. 8)

-107-

D. Other hypoproteinemic states.
Hypoproteinemia is ari extremely important consideration both from a medical and a surgical standpoint.
..1'-

/

In the whole of medical practice its prevention should
be an aim in all treatment, and its relief nmst be satisfactorily accomplished if the patient is to be given
his rightful chance for recovery.

In surgery, b9th pre-

and post-operatively, it is a most significant consideration.

In the diseases of, and in operations upon,

the liver, the bile ducts, and the rest of the gastrointestinal tract, it attains its maximal degree of importance. (235) (236)
One hundred and fourteen years ago, Dr. John
Bostock, chemist and physiologist of Guy's Hospital,
studied urin e and blood from Richard Bright's dropsical
patients.

In addition to his classical reports made to

Bright on the urine of these patients, he ventured to say
that the serum generally contained less albumin, than in
health.

Thus in 1827 a disturbance in the normal pattern

of the serum protein was established as a chemical characteristic of the diseased state.

(237)

Several disturbed physiological phenomena take
place in hypoproteinemia according to the physical laws
operating in the body.

The decreased concentration of
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the plasma prote i n within the blood vessels results in:
{a) a dimu.nition of the osmotic pressure within them;
(b) a shift of the electrolytes, and other crystalloids,
in the attempt to compensate for the decreased protein
concentration there; and (c) the accunru.lation of an increased amount of water in the extravascular spaces due
to the lowered osmotic pressure in the venous end of the
capillaries.

A considerable amount of excessive extra-

vascular fluid may accunru.late before the presence of
edema can be detected clinically.

However, long before

such hypoproteinemia manifests itself clinically, the
body reserve of protein has been nearly or entirely exhausted.

This is an effort on the part of the body ec-

onomy to conserve life by maintaining the plasma protein
as near the normal level as possible, and thereby preventing the disturbed physiology above mentioned. (238)
It has been shown by Addis, Poo and Lew, (239)
that the protein content of certain body viscera, especially the liver, is markedly reduced.

The stores of

protein mobilized under these conditions haYe been
designa ted by Whipple as

11

labile protein". (240)

Many of the patients coming to the surgeon for operation have, as a result of restriction in diet, resulting from a variety of causes; from visceral injury, or
from extensive plasma loss, a reduction not only in the
concentration of plasma protein, but also in the total
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available plasma protein.

Even though the concentration

of plasma protein is normal when the patient is first
seen, it frequently falls sharply when fluids are admin-

~---

istered in attempting to combat an existing dehydration.
Ravdin., (241) believes that "there is no\ such thing as
a critical level at which edema manifests itself".

He

states that as soon as the plasma protein falls below
the normal concentration, fluid beg i ns to leave the
vessels., resulting first in a latent., and final l y., when
the accUim.1lation of fluid in the tissues is great enough,
in an evident edema.

fuus in the presence of hypoprotein-

emia, attempts to restore normal fluid and electrolytic
balance without., at the same time increasing the colloid
osmotic pressure by adding to the plasma protein, too
frequently results only in adding to the extravascular
fluid already escaped from the vessels.
The state of hypoproteinemia results from the following causes: (242) (243)
1. Inadequate protein intake.
Economic causes, ( "hunger' edema).
Poor appetite.
any protracted illness.
cardiac deeompensation.
chronic alcoholism.
Mechanical interference with food intake.
Poor intestinal absorption.
2. Excessive protein loss.
Nephrotic state.
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Recurrent hemorrhage.
Massive chronic suppuration.
Severe burns.
Uncontrolled diabetes mellitus.
Various enteroenterostomies.
Repeated abdominal taps.
.,, _,,.,,.,_,,--,·-~

3. Failure of albumin synthesis.
Chronic parenchymatous liver disease.
Nephrotic s tate.
Cardiac edema with chronic passive congestion.
Prolonged protein starvation.

The treatment of nephrosis has b een especially
inter esting to clinicians because in this disease, edema
is usually found without complic a ting cardiac · or arterial
lesions.

In nephrosis the kidney need not be severely

damaged, and even in the stages of greatest disturbance
in water excretion, tests for renal f unction may give
approxima tely normal results.

Other than albuminuria

there is no evidence of renal damage.

(244)

Such ob-

servations have naturally stinmlated search for therapeutic agents, which act elsewhere than on the kidneys,
for patients with this condition.
Goettsch, and Kendall, (245) have shown that abnormal albumins and globulins appear in the serum of
nephrotic patients.

They further observed, that anti-

serums prepared from the abnormal serum proteins, obtained from nephrotic patients, do not react with norrr..al serum albumins and globulins.
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A phenomenum of great interest to clinicians is
the loss of serum albumin in nephrosis.

Aldrich, Stokes,

Killingsworth, and McGuiness, (246) in a preliminary report in 1938, state that,

11

while all the plasma proteins

are reduced, the most marked loss occurs in the albumin
fraction, and this results in a reversal of the albuminglobulin ratio".

This marked reduction in the albumin

fraction reduces the osmotic pressure of the blood plasma,
thus, theoretically, allowing for an escape of water into
the tissues.

Working on this premise these men treated

9 patients with true lipoid nephrosis by intravenous
injection with concentrated pooled human serum.

In some

cases they were able to obtain spectacular results, while
in others the results were disapp ointing.

In a later re-

port by Aldrich and Boyle, (247) in 1940, further experience with 7 additional patients is given.

They were

able to demonstrate at this time that the treatment with
four-times concentrated serum usually appeared effective,
as diuresis and weight loss followed the serum administration; and that in most instances diuresis, once initiated,
continued to complete elimination of edema fluid without
additional serum.

They were able to obtain their best

results in those patients treated earliest, suggesting
that this method should be used by first choice instead
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of as a last resort.

Loeb, (248) on the other hand,

reports that his experience with plasma transfusions
in nephrotic patients, while limited, has been uni-

__ ______.,.

formly disapp ointing.

He cites the case of a nephrotic

patient who before treatment with 2000 cc. of normal
human plasma, in the course of 3 days, had a serum
albumin level of 1.3 grams, and at the end of this
time showed only a level of 1.5 grams.

It is to be

noted, h owever, that normal and not concentrated plasma
was used.
Strumia and McGraw, (249) (250) state that plasma
is indicated in the treatment of nephrosis, and cite
a case, suffering from nephrotic hypoproteinemia in
the cour s e of chronic nephritis, who responded satisfactorily to t he administration of 710 grams of plasma
protein, (10,000 cc. of undiluted plasma), over aperiod of 12 days.
The surgeon has become increasingly concerned
with the nutrition of the surg ical patient, since it
has been shown that a variety of lesions complicating
operations are the result of nutritional disturbances.
Jones, Eaton and White, (251) (252) have reported on
the hazards resulting from hypoproteinemia in patients
subjected to surgery.

They present data on 34 patients
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who developed a critically low amount of serum protein
following routine surgical procedures .

Their sugges-

tions as to the correction of this condition are mainly

---

from the standpoint of diet, but they also make the observation that "transfusion of plasma alone would be
the most advantageous procedure , if such a procedure
could be carried out".

The fact tha t the above obser-

vation was made in 1933 precludes, of course, the use
of plasma transfusion as a proven measure in such cases.
Mecray , Barden, Frazier, and Ravdin, (253) (254)
have shown in the dog, tha t even in the presence of an
intact gastrointestinal tract, a reduction in the plasma
protein concentration will result i n a mar ked increase
in the normal gastric emptying time, and a further delay in the cecum .appearance time.

Ravidin, (255) states

that he has noted in a number of instances after operations on his own, and other surgeon's patients, that
the gastric emptying time may be so prolonged as to
simulate a technical defect in the anastamosis .

He

concludes that the so-ca l led "vicious circle" more often
results from the disturbance in the normal movement of
fluids, than from technical defects in the new anastomosis .
Fine, Hurwitz and W
J.ark, (256) present experimental
and clinical evidence to show that uncomplicated obstruc-114-

tion to the small intestine may cause a fall in the
circulating plasma volume sufficient to account for
death.

This fall in plasma volume occurs in signifi-

cant amounts, "only when a substantial degree of distension, mechanical or functional in origin, occurs;
and distention of the colon and of the gallbladder
does not cause a significant loss of plasma, while
distention of as little as 2 feet of the small intestine may do so".

The mechanism by which distention

causes the plasma loss appears to be uncertain.

In

regards to therapy in such conditions, the authors
st ate that decompression of the small intestine will
restore the plasma volume toward normal, but make no
mention of the obvious indication for plasma transfusion.
Ravdin, (257) states that the prolonged interference with normal diet in many of of the patients
coming to operation for peptic ulcer and gastric
cancer, has frequently resulted in varying degrees
of under nutrition.

This author also suggests that

the convalescence of such patients will be smoother
and the incidence of untoward complications will be
reduced, if nutritional deficits are, if possible,
corrected prior to operation, or as soon as possible
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after operation.

While the high carbohydrate-high

protein diet given by mouth is the most satisfactory
means of supplying the nutritional re quirements of
surgical patients, it is fre quently impossible to get
the patient to take sufficient calories prior to operation, either because of anorexia, or because of pain
or obstruction.

Trie very nature of the surgical pro-

cedure often precludes the oral intake of food for a
period after operation.

Ravdin, (258) states that he

and hi s co-workers have found that repeated small transfusions of plasma are the most rap id means of correcting such protein deficienc _ies.

In a later report,

Ravdin, Stengel and Prushankin, (259) the use of lyophile serum is mentioned as giving temporary elevation
of the serum protein, but warns that "some very annoying reactions" have occurred with its use.
Another surgical problem in connection with hypoproteinemia is that of delayed wound healing.

Smelo,

(260) in a study of wound healing made in 1935, concluded that "factors other than the local dressings
appear to play the dominant role in determining the
rate of wound healing~ Ravdin, (261) found that dogs
made hypoproteinemic by prolonged fe eding of a low
protein diet and plasmapheresis, had a marked delay
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in fibroblastic proliferation, and thus a retardation
in wound healing.

By employing plasma transfusions

he was able to restore the depleted protein stores,
allowing the prompt healing of the wounds.

Whipple,

(262) in a report on wound healing, given before the
American Surgical Association in St. Louis in 1940,
indicated the need for hematocrit and blood plasma
determinations before, during, and after operations
as an aid to the prompt healing of wounds.

Protein

deficiency is, of course, not the only mechanism
resulting in delayed wound healing, but nevertheless
is an important consideration to keep in mind when
all the local factors favoring delayed wound healing
are controlled.
That a high carbohydrate dietary regime is efficacious in preventing liver injury, is agreed to by
every clinician who has administered such a diet in
patients with hepatic disease.

The value of a high

liver protein content in protecting this organ from
injury is suggested by Ravdin. (263)

He postulates

that, "a liver high in lipid content and low in protein is maximally susceptible to injuryn; and that,
"carbohydrate is advantageous only if, during its
deposition in the liver, fat is displaced, and if as
a result of an adequate store of hepatic glycogen,
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hepatic protein is spared".

This is confirmed by the

findings of Miller and Whipple. (264)

Strumia and

McGraw, (265) state that plasma. transfusion is indicated in cases of hepatic hypoproteinemia, and cite a case
of theirs, with a subacute hepatitis, re quiring 518
grams of plasma protein, (over 7500 cc. of undiluted
p lasma), to tide him over a period of 19 days, including an extensive op eration to relieve his obstruction
a t the ampulla.

T:h.ese men recommend the following as

regards dosage of plasma in cases of hypoproteinemia-11hypoproteinemia is usual l y well corrected beyond the
danger limit by the transfusion of 35 grams of plasma
protein, (500 cc. of undiluted plasma ).
The recognition of the above important facts op ens
up a field of usefulness for plasma transfusions which
has been more or less neglected heretofore.

In any

i llness of such a nature that the oral intake of protein is prevented, or is inadequate for more than a few
days, the patient becomes a candidate for plasma transfusion.

In those instances in which the illness is of

a longer duration, or is as s ociated with los s of serous
fluid from the body, repeated transfusions of plasma
are necessary to support the patient and give him a
better chance for recovery. (266)
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Edema

c.

Miscellaneous conditions.
Infectious diseases.
The development of improved technical procedures

for preservation, pooling, and concentration of plasma
and serum, have considerably facilitated the utilization of human serum in the treatment of the infectious
diseases.
McGuines s and his co-workers, (267) present one
of the most complete reports along this line of endeavor.

They used human serum prepared by the lyo-

phile process in the prophylaxis of scarlet fever,
measles , mumps , chickenpox, whooping cough, and German
measles; and in the treatment of scarlet fever, nru.mps ,
erysipelas, whooping cough, and acute hemolytic streptococcal infections.

They particularly emphasize the

use of serum from l arge pools of normal healthy adult
blood, in the prophylaxis of the more connnon contagious
diseases.

They contrast their results in most instances

with those of others using convalescent serum.
(a) Scarlet fever.
A group of 47 individuals exposed to scarlet fever
were given pooled adult serum from Dick negative individuals as a prophylactic measure .

Of this group two

developed very mild scarlet fever, although thirty-three
of them were known to be Dick positive, and subjected
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to a very long intimate contact with the disease.
'Ib.ese results are compared with a series of 1933 contacts
given convalescent serum, of whom, 2.5% developed the
disease.

The authors suggest that in the absence of

convalescent scarlet fever serum, pooled adult serum
from individuals with negative Dick tests may be of
prophylactic value.

I am unable from their report to

derive any conclusions as to the use of pooled adult
serum in the active treatment of scarlet fever.
(b) Measles.
None of the cases receiving either convalescent
serum or pooled adult serum, as a prophylactic measure
against measles, suffered any sequellae.

The concen-

tration made possible by the use of lyophile serum,
makes the size of the dose comparatively unimportant.
Its relatively low cost, and availability in any amount
desired, appear to make this procedure the one of choice,
since results with either type of serum are the same.
A dose of 2.5 cc. per year of age injected on the 7th
day of continuous intimate exposure was used.
They report that the use of lyophile serum as a
therapeutic measure in the active treatment of measles,
has been attempted in only a few c a ses and no conclusions could be drawn.
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{c) iwnps.

Pooled normal adult serum and convalescent serum
were used as a prophylactic measure in 140 cases, of
which nine developed the disease.

Of these 9, 6 were

in the group receiving convalescent serum, and 3 in
the group receiving human pooled serum.

Since the

ratio of those receiving convalescent serum was larger
than those receiving pooled adult serum, no comparative
re sults are obtainable.

It does appear, however, that

the latter may be of prophylactic value.
{d) Chickenpox.
The use of pooled adult serum as a prophylactic
measure against chic kenpox did not appear to be as
effective as when used in the prophylaxis of measles.
The number of failures occurred, however, when comparatively small doses of pooled adult serum were used as
against adequate doses of convalescent serum in the
successful cases.
(e) Erysipelas.
Three cases of erysipelas were treated with pooled adult s erum, all of which made good recoveries.

The

injection of the serum was follo wed by a fall in temperature, reduction in toxemia, and a fading of the rash.
T.hese patients rec e ived from 2 to 4 injections varying
from 30 to 60 cc. each.
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(f) Whooping cough.
Pooled adult serum was used in the prophylaxis of
whooping cough in a group of 12 infants between the ages
of one and seven months.

Serum was injected on the 12th

day following exp osure, in amounts from 10 to 20 cc.
None of these infants developed whooping cough.
In the active treatment of the disease, 15 cases
were treated with a pooled adult serum prepared from
healthy adults after they had received a routine course
of Sauer's vaccine.

Five of these cases appeared to be

improved aft er t h e injection of the serum, but its value
in the remaining ten cases was questionable.
(g) German measles.
Pooled adult serum wa s used in an outbreak of
German measles in which 10 infants between the ages of
6 and 10 months, and one infant 4 months of age were

affected.

Each was injected with 10 cc. of t he serum

on the day that a typical case of German me a sles was
discovered among them.

Of the 11 cases receiving serum

1 developed the disease 12 days after the initial exposure.
(h) Acute streptococcal infections.
A relatively small series of cases of hemolytic
streptococcal infections were treated with pooled lyophile seru.~.

Among these were 6 cas e s of acute hemo-123-

•

lytic streptococcal laryngitis, 3 cas es of hemolytic
streptococcal meningitis , 7 cases of severe hemolytic
streptococcal sore throat, 2 cases of acute mastoiditis,
1 case of puerperal sepsis with an associated streptococcal septicemia, and 1 case of hemolytic streptococcal septicemia of obscure origin, which were treated.

No final conclusions could be reached but the

results obtained in a number of instances suggested
considerable benefit from this type of therapy .

In

the light of present day knowledge such cases of course,
would be relegated to sulfonamide therapy.
While the above report is admittadly inade quate,
other than it, only scattered isolated references to
the use of blood plasma or serum, as pertinent to this
particular subject could be found.
Ravitch and Blalock, (268) reported that only whole
blood, plasma, and serum can be expected to supply complement and imnru.ne bodies in states of infection, and
that any blood substitute which supplies utilizable protein will indirectly aid antibody formation.
Madden and Whipp le, (269) state that saturation of
the plasma protein storage depots is important in the
production of antibodies, which is of obvious importance
in the general therapy of infectious diseases.
In regard to dosage of plasma, when it is used for
its content of specific and nonspecific antibodies,
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Strumia and McGraw, (270) state that, "dosag e is a
matter based mostly upon clinical appraisal, and
consequently the proper amount to be used is difficult
to estimate accurately".

They indicate, however, that

for prophylaxis or modification of many infectious diseases, especially measles and scarlet fever, the use
of pooled adult plasma has given gratifying results,
and suggest the average dose should vary from . 7 to
3.5 grams of plasma protein, or from 10 to 50 cc . of
undiluted plasma .

In prolonged infections the role

of plasma in correcting hypoproteinemia, must be considered in addition to any eff ect of specific and non. specific antibodies.

T:h.ey likewise stress that pro-

longed preservation of antibodies in plasma can only
be accomplished by pres ervation of the plasma in the
frozen state, or by desiccation from the frozen state.
Tr.te application of this statement to the treatment of
infections by p lasma transfusion therapy is obvious.
;rncreased intracranial pressure.
From a theoretical standpoint, the ideal hypertonic solution capable of reducing intracranial pressure, is one that not only has a high osmotic pressure,
but also contains solutes which will remain in the
blood vessels after injection in order to exert a continued osmotic effect.

(271) The normal impermeability
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of the blood capillaries to the serum proteins in man,
thus suggest a therapeutic measure of value in plasma
protein transfusions for the relief of increased intracranial pressure.
Hughes, Mudd and Strecker., .( 272) have shown that
concentrated solutions of human serum are highly effective in reducing increased intracranial pressure for relatively long periods.

They tried both serum dissolved

in 50% sucrose solution, and in water, concluding that
the latter was the best solvent., as the sucrose-serum
mixture was difficult to give intravenously due to its
viscosity.

Theoretically, of course, the sucrose-serum

solution should have an added advantage of an increased
diuretic effect due to the hypertonic sucrose.
Hill, (273) suggests the use of plasma in concentrated form for its hypertonic effect., in the therapy
of increased intracranial pressure.

He states that,

"the increased osmotic pressure makes it possible to
reduce increased i ntracranial pressure, such as is encountered in cerebral edema from head injuries, and in
eclampsia 11 •

This same author in another article, (274)

indicates tha t hypertonic plasma proteins are superior
in the treatment of conditions of increased intracranial
pressure because of the prolonged osmotic effect of such
solutions.
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Toxemias of pregnancy.
Until recent years it has been assumed that restriction of protein is of benefit in the toxemias of
pregnancy, and only of late has the high-protein, lowsodium diet come into more general acceptance.

The

problems of protein metabolism in pregnancy are far
from solved, but it is clear that diminished plasma
proteins may be associated with generalized edema in
the eclamptic, and in the nephrotic.

Replacement of

the colloidal elements might , on this basis, well be
considered a primary aim of therapy.
Benaron and Farnsworth, (275) working on the above
basis, report a case of eclampsia treated by the intravenous in j ection of 750 cc, (52 grams total protein),
of blood serum in two transfusions.

Following the ad-

ministration of this serum, diuresis occurred -- the
output rising from 690 cc. to 1890 cc.-- accompanied
by a drop in the specific gravity of the urine from
1.023 to 1.015, and a diminution in blood hematocrit
from 51.9 to 45%, indicating a sharp dilution of the
existing hemoconcentration.

The prior use of crystal-

loids in the form of hypertonic glucose and magnesium
sulphate failed to bring about these results.
Dexter and Weiss, (276) however, are not in accord
with the view that the primary cause of edema in pregnancy is due to a lowering of t h e plasma protein,
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stating that,

11

it is not rare to find anasarca in pa-

tients whose plasma proteins are relatively normal 11 •
Mahoney and his co-workers, (277) reported their
experience with four patients with toxemias of pregnancy treated with plasma transfusions, but stated
that their results were not conclus ive, although it
seemed possible to prevent a critical fall in the
leve-1 of circulating protein.
As an aid in the treatment of malaria.
Fawcett and Walters, (278) report the case of
an Indian sailor who contracted acute malignant tertian malaria while sailing from India to England.
Upon arrival in England he was very ill.

Treatment

was instituted at once, consisting of 9 grains of
quinine dihydrochloride intramuscularly, once daily,
and one grain of atebrine, three times daily.

No

improvement in his conditi on was noted the following
day, and his prognosis caused cons iderable anxiety.
The next day he was given, in addition to his regular
treatment, 400 cc. of re-constituted serum at 3: P.M.
By 5:15 P.M. he was much improved and two days later
his temperature and urine were normal, he was taking
a normal diet, and parasites were absent from his
blood.

It is suggested that the action of the serum
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in this case was two-fold-- tending to dilute, and to
some degree neutralize, the malarial toxins; and to
minimize t h e quinine shock sometimes sustained by toxic
debilitated patients of this type.
Blood plasma in the restoration of the physiolgi~
balance in the sick child.
Andrews, Elliott and Busby, (279) point out that
circulatory failure accompanies many medical and surgical diseases , and that in the sick child, the younger
the patient, the earlier t h e onset of circulatory failure.

Also , in the sick child, the subjective symptoms

marking the onset of circulatory failure are not present,
as in the adult traumatic, surgical, and obstetrical
patient .

Since circulatory failure is a reduction of

the blood volume due to loss of plasma through permeable
cap illary walls, they have tried plasma transfusions
routinely on their pediatric service in cases of pneumonia , diptheria, colitis, surgical lesions of the gastrointest i nal tract, in all c ases with signs of circulatory
failure, and report that the judicious use of blood
plasma in the early course of severe illness obviates
circulatory failure.
Hemo£hilia .
Ma.honey, Kingsley and Howland, (280) report treating three hemophiliac patients with plasma transfusions.
One of these had been under treatment for sev eral years,
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and had become sensitive to whole blood transfusions
in spite of careful group ing and cross-matching.
They were able to maintain the clotting time of the
blood at a low level by using 50 cc. transfusions of
plasma weekly , or bi-weekly.
Payne and Steen, (281) reported the use of human
blood plasma in hemophilia, and found that the only
form of treatment of real value was the intravenous
injection of either citrated whole blood, or citrated
human plasma.
A recent report by Johnson, (282) indic ates the
effectiveness of dried human plasma in the manag ement
of hemarthrosis, hematuria, and in tooth extractions,
and as a prophylactic against recurrent hemorrhages,
in patients with hemophilia.

About one hundred injec-

tions of plasma were given to five patients without
typing.

In several instances of hemarthrosis , the

patient indic a ted relief of symptoms, referable to the
joint, within a few hours after plasma was injected
intravenously.

Improvement continued rapidly to com-

plete healing in these cases.
ported as responding promptly.

Hematuria was also reOne patient with a

massive hematuria was given 200 cc of plasma during
the first twenty-four hours of his admission.

At the

end of thirty-six hours the hematuria was greatly
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reduced; at the end of forty-eight hours no gross blood
was detectable; and in twelve hours more the guaiac
test was negative.

One of the most satisfactory results

of plasma transfusion in these patients, was the elimination of the fear of tooth extraction, and consequent postoperative hemorrhage.

This was done by administering a

dose of 150 cc. of plasma which reduced the coagulation
time to normal.

The teeth were at once extracted and

the tooth sockets packed with dried plasma.

Dried plasma

transfusions were subsequently given over a period of a
few days, keeping the coagulation time at twenty minutes
or less.

The effectiveness of this type of management

is apparent from the f act that the red cell count, and
the hemoglobin level, were essentially the same seven
days after extraction, as they were before.

An effort

was also made to rehabilitate a patient totally disabled
by hemophilia, with weekly injections of 125 cc. of
plasma over a period of three months.

This patient had

a coagulation time, before therapy, of about 100 minutes,
and his activities had been greatly restricted due to
recurrent hemorrhages.

During the period of treatment

he was able to rehabilitate himself to the extent of
doing light work.

He was comparatively free from hem-

orrhages, his coagulation time was near normal during
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the first twenty-four hours after his injections,
gradually rising to about sixty minutes at the end
of six days.

'l'.he author states that "it appears that

the intensive treatment of incipient hemorrhages with
plasma is the most satisfactory method used in the
effort to rehabilitate patients suffering from hemophilia, and is of great benefit in meetin many of the
critical emergencies in the lives of such patients."
Hemorrhagic disease of the newborn.
Ma.honey and his co-workers also used lyophile
serum to treat four infants with this disease.

One

patient developed hemorrhagic tendencies on the second
day of life and was given 60 cc. of plasma.

Eight min-

utes later the micro-prothrombin time had changed from
a level of 6 minutes-19 seconds/45 seconds, prior to
administration, to 52 seconds/37 seconds, afterward.
~e next day the micro-prothrombin time was 33 seconds/
26 seconds.

All four cases showed a similar response,

producing a very rapid decrease in the prothrombin time.
Strumia and McGraw, (283) state the the hypoprothrombinemias are usually well corrected beyond the
danger limit by the transfusion of 35 grams of protein,
(500 cc. of undiluted plasma).

For routine use he and

his co-workers at Bryn Mawr Hospital keep on hand bottles
of 12 to 15 cc. of undiluted plasma proteins made from
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a pool of several fresh bleedings.

'.J.'

his allows them

an easy means of raising the prothrombin level of the
newborn in the shortest possible time.
Intestinal obstruction.
Gendel and Fine, (284) studied the effects of
distention of the intestinal tract of dogs on the
volume of plasma and on the total blood volume in dogs.
lb.ey concluded that the plasma volume loss was due, at
least in part, to capillary leakage of plasma in a manner similar to that occurring in traumatic shock, and
that death from acute intestinal obstruction could be
attributed to crucial changes in plasma volume due to
the factor of distention alone.

They feel that loss of

plasma is an early and basic process in the syndrome of
intestinal obstruction as evidenced by the extent of
plasma loss as e arly as the fourth hour after the onset
of distention.

Thus t his indicates that the replacement

of plasma is as essential as any other therapeutic measure with the exception of the necessity of relieving
intestinal pressure.

'Ibey indicate that the administra-

tion of plasma is necessary long before any evidence of
shock is indicated by the level of the blo od pressure,
the latter being a rather misleading guide to the patients
condition.

The hematocrit, they suggest, will be a more

accurate guide t o the patients need for plasma.
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In an additional study by Fine and Gendel, (285)
an attempt was made to inquire further into the exact

mechanism of the plasma loss in acute intestinal obstruction.

Five dogs were subjected to intestinal dis-

tention at a pressure of 20 cm. of water, and plasma
was administered continuously intravenously to replace
part or all of the anticipated loss.

The plasma vol-

ume of these dogs was effectively maintained as long
as the supply of intravenous plasma was adequate, but
upon interruption of the admi nistration of plasma, a
drop of plasma volume sufficient to cause death occurred.

Tile survival time of the dogs receiving plasma

was increased some forty hours over those not receiving
plasma.

They conclude that the loss of plasma continues

so long as distention continues in the obstructed small
intestine of the dog.

The extent of t his loss, if un-

compensated, is sufficient in itself to cause death,
and is of primary importance in the pathological physiology of intestinal obstruction.

No conclusive mech-

anism could be demonstrated for the loss of plasma in
cases of acute intestinal obstruction, however their
studies suggested that part · of the plasma is forced into
the interstitial spaces of the pelvis and lower limbs
because of impeded venous return from t hese areas.
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The

obvious inference from these observations, if they are
correct, is that transfusions of plasma, in sufficient
volume to replace the plasma which is lost, should have
a favorable influence on the course of acute intestinal
obstruction.

-135-

VII.

NEWER BLOOD SUBSTITUTES.
While not entirely within the scope of this paper,

the present effort to find other blood substitutes which
are more economically suitable for the treatment of shock
and hypoproteinemic states, makes it advisable to include
a brief discussion of these agents.
1. Human albumin.
It has been found possible to separate the various
fractions of human plasma.

The albumin fraction makes

up 65% of the proteins of the plasma., and exerts 85% of'
the colloidal osmotic pressure provided by plasma protein.

100 cc. of 30% human albumin exerts approximately

the same colloidal osmotic pressure, when injected intravenously, as 1000 cc. of whole blo od, or 500 cc. of normal plasma.

Refrigeration is unnecessary with albumin and

it is amenable to packaging in small units ready for immediate use. (286)
Experimental and clinical studies carried out at the
Army and Navy Medical centers, and in several large hospitals have proved it effective in restoring blood volume
in shock.
2. Bovine £lasma.
Wangensteen and his co-workers, (287) have given
bovine plasma an ade quate clinical trial.

It cannot at

present, however, be considered a satisfactory blood substitute, as alarming systemic reactions often follow its
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use.
3. Bovine albumin.
Janeway, (288) has reported on the clinical use
of bovine albumin, stating that "it is too early to
evaluate this type of work, but it represents an important approach to the problem of providing cheap and
readily available blood substitutes".

Cohn, (289) and

his associates, also used bovine plasma as a source of
purified albumin in their experiments.
4. C_rystalline hemoglobin.
Janeway,(foregoing), also reports the feasibility
of using this product as a blood substitute .

It was

tried in an effort to find a substitute that would be
able to carry oxygen, as well as aid in restoring blood
volume in shock.

The quantity needed in the treatment

of shock is considered to be fairly dangerous, as in
the presence of an acid urine, hemoglobin may be precipitated in the kidney tubules, with resultant anuria
and kidney damage.
5. Pectin.
Hartman, (290) and his associates have reported
on the use of pectin as a blood substitute in the treatment of shock.

It is apparently a nontoxic, non-antigenic

colloidal carbohydrate, having a relatively high molecular
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weight and a complex composition.

Preliminary experi-

mental and clinical studies appear to indicate that
solutions of pectin are valuable in the treatment of
shock.

However , this product must undergo exhaustive

studies before it can be considered a dependable agent.
6. Isi!!B,lass.
Taylor and Waters, (291) report a solution of
isinglass, (fish gelatin), to be effective experimentally in restoring the blood pressure in dogs following
hemorrhage .
7. Casein hydrolysate .
Whipple and h is co-workers, (292) have shown that
a mixture of amino acids and polypeptides derived from
casein, (casein hydrolysate), given intravenously, stimulate plasma protein production.

This would not necessa-

rily be indicated in the treatment of shock, but might
be used to combat hypoproteinemia in patients who are
unable to take dietary protein by mouth.
It is obvious that all of the above blood substitutes are only in the experimental stages, and their
use cannot be considered satisfactory at present, nor
do they present a serious competative relation to the
use of plasma therapeutically, at present.

However, the

rapid progression of the science of transfusion during
the past year, makes it imperative that one tread lightly
in his forecasts for the future.
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VIII.

MILITARY ASPECTS OF BLOOD PLASMA TRANSFUSION.
As early as 1918 Ward, (293), of the British Royal

Army Medical Corps, made an unheeded plea for the use
of human plasma in the treatment of war casualties.
As was before stated, the first world war was instrumental in creating interest in the use of blood substitutes for treatment of casualties incident to war
conditions.

Experimental and clinical investigation

followed, and the beginning of hostilities in Europe
in 1939, created a further interest in the use of human blood plasma in the emergency treatment of shock,
hemorrhage, and burns.
Early in 1940 the Allies suffered severe reverses
at the hands of the highly mechanized German armed
forces.

The Surgeons General of the Army and Navy of

the United States, realized that due to the gravity of
the international situation our Armed Forces should be
prepared for any eventuality.

In J!Jay of 1940 they re-

quested the aid of the National Research Council in
determining and obtaining for use, large quantities of
the best blood substitutes for our Armed Forces.

Two

committees were appointed by the Council, a Committee
on Transfusions, and a Subcommitte on Blood Substitutes,
and were informed of the problems confronting the Army
and Navy in the procurement of adequate quantities of
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suitable blood substitutes. (294)
Because of the lack of uniform opinion at that
time as to the best method of preparing human plasma
for use in the military forces, the members of these
committees investigated methods of preparing plasma
and serum, means of blood procurement, transportation,
and preservation of whole blood.

From these studies

it was concluded that dried plasma was the blood substitute of choice for use in the armed services because
of its many advantages over other forms of blood substitutes and whole blood.
In February 1941, based on these recommendations,
the National Research Council instituted a program to
furnish 15,000 packages of dried plasma for use in the
.A:rmy and Navy, each package to contain the dried materiel obtained from 250 cc. of original plasma, a bottle
of sterile pyrogen-free distilled water, and the necessary intravenous equipment.

In May 1941, the Council

made an additional request for 200,000 packages.
To carry to fulfillment a program of such magnitude required the participation and cooperation of,
(1) the general public, (2) the American Red Cross and
the General Hospitals, (3) the commercial biologic firms,
(4) the Army, (5) the Navy, and (6) the National Research
Council.

The parts played by each of these organizations
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may be briefly outlined as follows:
1. 'I'b.e general public.
The voluntary contribution of blood by the general public is obviously necessary for the success of
a blood plasma program of this scope.
2. The American Red Cross and the General Hospitals.
The American Red Cross with its many chapters
across the nation was well fitted for the enrollment of voluntary blood donors.

It is financing all

costs incident to the collection and shipment of blood
to the commercial biologic forms.

Blood collecting

stations and blood donor centers have been set up in
various sections of the country.

The general hospitals

since they already have had experience in this type
of work, and since they are conveniently available
to the public donors, also can readily accomplish
the collection of blood and affect its transfer to
the nearest "drying unit".
3. Commercial biologic firms.
Licensed laboratories have been selected according to geographic location and their facilities for
preparing dried plasma.

These firms were given contracts

to process dried plasma according to the s p ecifications
prepared by the Army and Navy.
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Blood is collected at

various donor centers, Red Cross and Hospital, and
shipped to these firms from a radius of several hundred miles.

The blood is then centrifuged, serologic

tests made, the plasma pooled and cultured, and the
required amount of liquid plasma placed in containers
and frozen.

The plasma is then dried from the frozen

state under high vacuum.

After desiccation had been

completed the material is sealed and packaged for
shipment.
4. The Arrrry.
The Army Procurement Division, Medical Depot, New
York City acts as purchasing agent for all plasma prepared connnercially for use in both the Army and Navy.
5. The Navy.
Dried plasma purchased by the above division is
shipped direct to one of the Naval Medical Supply depots, and is distributed from there to the ships and
Naval Stations beyond the continental limits of the
United States.

Plasma prepared by the Naval Medical

School, Washington, D.

c.

is supplied to other Naval

activities.
6. The National Research Council.
The Subcommittee on Blood Substitutes of the Council, with representatives of the Army and Navy, study
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the progress being made in the various phases of research on blood substitutes, and report to the Council
their findings.
The above program is now reported to be functioning, and all combatant ships and other naval medical
units now have a supply of dried plasma on hand .

It

is anticipated that a large reserve supply of this product will be available for the Army and Navy within
the ensuing year.

The "pilot'' contract of 15,000 units

first requested by the Council, and let to one biologic
firm, was mainly taken up by the Navy.

Future division

of packages of dried plasma probably will be based upon
the immediate needs of the two services, Army and Navy.
A clinical trial of concentrated dried plasma was
made at the Army and Naval Medical Centers in view of
the possibility of providing a smal ler package of plasma
to be u s ed by the armed forces.

Space is necessarily

at a premium, especially aboard the combatant ships,
in landing parties, invasion armed forces, and at the
battle front.

These studies, however, indicated that

four times concentrated plasma was not as effective in
the treatment of traumatic shock as was normal plasma .
These findings are in accord with those of Mahoney mentioned previously.

As a result of this study, and the
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experience of other investigators, it was recommended
that the Army and Navy use normal plasma and not concentrated plasma in the treatment of secondary shock.
The adoption of plasma, as an adequate substitute,
was a distinct advance in making available to the armed
forces, a colloidal substance suitable for the treatment of shock, burns,and hemorrhage. For the purpose of
plasma preservation, under ordinary conditions, the frozen state appears to be the method of choice; but in
conditions of wartime the acceptance of drying provides
certain advantages.

It remained to develop a method of

packing plasma so as to make it available for use in the
field and aboard ship.

As a result of the work done by

members of the Subconnnittee on Blood Substitutes, the
standard package described below was accepted for use
in the armed forces.
The completed package consits of two 400 cc. bottles
stoppered with hood type rubber stoppers, and complete
equipment for intravenous administration, sealed in metal
cans, and packaged in a tape-sealed waterproof fiberboard
box.

One bottle contains the dried plasma obtained from

300 cc. of citrated plasma, and is evacuated and sealed
under 73.6 cm. of vacuum.

The solids should contain 17.5

to 18 grams of plasma proteins.
-144-

This bottle is fitted

with a cloth tape for suspending it in the inverted
position while the plasma is being injected.

The

other bottle, sealed without a vacuum, contains 300
cc. of sterile pyrogen-free water.

The equipment

for intravenous administration consists of an airway assembly and an intravenous injection set.

The

airway assembly consists of 9 inches o~ rubber tubing
with a needle attached on one end for insertion into
the rubber stoppers, . and a cotton f i lter on the other
end.

The intravenous injection set consists of 48

inches of rubber tubing which contains a glass cloth
filter for filtering the .plasma as it is administered.
At one end of the tube is a glass adaptor, fitted to
an 18 gage intravenous needle, and at the other end
is a short 15 gage needle which connects the set to
the plasma bottle.

The bottle containing the dried

plasma, along with the injection needle, clamp, and
double ended needle, used for adding the distilled
water to the plasma, is placed in one can which is
evacuated to 63.5 cm. of vacuum and sealed.

The

bottle containing the distilled water, the intravenous
injection set, and the air filter, are sealed in the
second metal can, which is filled with dry nitrogen.
Instructions for the preparation and use of this material are lithographed on the can containing the plasma
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bottle.

Both cans, tog ether with a questionaire for

recording data on the use of this unit, are packaged
together in the tape-sealed waterproof fiberboard box.
The finished package has at one end, a Red Cross label,
indicating that the blood, from which the contained
plasma was made, was furnished by vol unteer Red Cross
donors.
The packages as above described were put through
tests repeatedly under actual combat c onditions from
May until September 1941 by units of the .A:rmy and Navy
forces.

They then were returned to t he Navy Medical

School where t h ey were found to be in gooa condition.
The complete approval of the Surgeons General of the
Army and Navy was then given this packaged p lasma unit.
At present all units of the armed forces have been
supplied wi th this package, and while reports, at present
are me ager concerning its actual usag e under war conditions, it represents a great step forward by medical
science in providing an adequate blood substitute for
the treatment of traumatic shock, with or wi thout hemorrhage, and burns in wartime and in future civilian
use.
T.he above discussion has been com.piled from the
following references: (295) (296) (297) (298) (299)
(300) (301) (302) •

The important role of blood plasma was illustrated
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in the torpedoing of the

u.s.s.

Kearny.

In this case

blood plasma was dropped by parachute from a plane into
the sea, recovered from the water, re-sterilized, and
administered to a sailor aboard the torpedoed vessel.
The sailor, whose life had been considered in grave
condition, showed steady improvement after several
transfusions with blood plasma. (303)
There is a considerable difference of opinion by
various military forces as to the choice of blood and
blood substitutes.

The Russian Army usually utilizes

whole blood for transfusion, only universal donors
being used in military zones.

Plasma or serum is rarely

used, unless recent changes have been instituted.
Germ.an Army uses only whole blood.

The

Both the civilian

and military personell are typed, and blood from only
universal donors is used.

Interestingly enough it is

reported that blood is taken only :from those of "pure
Aryian" stock.

The British Army prefers liquid plasma

or serum, although the Royal Air Force is in favor of
the dried form of plasma because of its ease of transportation.

The prevailing opinion is at present that

the United States Army and Navy Medical Corps will prefer the dried form.

(304)
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IX. CONCLUSIONS.
A resume of the history of transfusional surgery,
including the beginnings of experimental and clinical
blood plasma and serum transfusions, has been given.
It must be emphasized again that the history of plasma
transfusion is indeed now in the making, and the present
war will add many pages to this history, as well as place
the use of plasma as a blood substitute on unquestioned
proven ground.
Whether blood plasma, or blood serum will prove one
better than the other, is still a moot question--and one
that does not appear to be answered by either experimental
or clinical investigation.

While it is true that serum

appears to cause more reactions than plasma, it is noted
that as better methods of preparation, preservation, and
storage have been applied to the production of each of
these products, the incidence of reactions has dropped
in both.

Since it appears that the therapeutic actions

of the two are very similar, improved methods of handling
may be a portion of the answer to this pertinent question.
The point Strum.la mentions in his preference for plasma
over serum, i.e., greater yield of plasma from a given
quantity of blood;

ease of coordination of production

of plasma with the functioning of a blood bank;
rarity of reactions, must be kept in mind.
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and,

It would be

the writers opinion that, for the present, at least,
blood plasma is preferable to blood serum.
In the selection of donors, under normal conditions,
one should preferably take individuals between the ages
of 21 and 45 who have a hemoglobin level above 13 grams.
The drawing of blood should be done at a time when the
donor is in a fasting state for the preceeding four hours
to avoid, as far as possible, the occurrence of reactions.
The amount drawn should be calcula t ed i n terms of the
donors weight--3.5 cc. per pound for males, and 3.0 cc.
for females.

A bacteriological study of the blood so

obtained should be instituted immediately, and the s t orage of this blood at 4 deg.

c.

over five days before

separation of the cellular elements is accomplished,
should be avoided.

The collection of blood is probably

best achieved by the use of one of the various types of
vacuum bottles, observing the rules of strict asepsis.
,

Centrifugation is .apparently the method of choice
to effect separation of the cellular elements, as it
produces a greater yield of plasma, is less liable to
contamination, and there is no loss of the more labile
portions of the plasma.

The plasma thus separat ed ,

should be p ooled in pools, preferabl y of about ten
bleedings each, and distributed from pools of this size
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into individual containers ready to be preserved by
any of the various methods.
Preservation by means of freezing or drying are
the only entirely satisfactory methods at present.
The use of the sulfonamide derivatives as a means of
prevention of contamination of plasma stored in the
liquid state, while reported on, must still be further
confirmed by other workers before being accepted.

It

appears to the writer that the method of preservation
should, in most instances, be correla ted with the situation at hand, as both frozen and dried plasma have
certain advantages and disadvantages.

The freezing of

plasma and storage in the frozen state is probably the
method of choice in civilian practice, as it meets the
es s ential requirments of a blood substitute in the greatest number of instances.

The dried state, however, is

preferable from a military standpoint, and under certain
emergency civilian circumstances.

It must likewise be

kep t i n mind that, at the present t ime, the method of
preservation greatly influences the survival of various
specific elements of the plasma--a point of significance
from a therapeutic standpoint.

From an economic view

the dried form is much more expensive to produce than
the frozen product.

Of the numerous meth ods rep orted,

wh ereby dry ing of plasma is accomplished, one involving
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vacuum sublimation is probably preferable. For large
scale production the "Desivac 11 process appears to be
the most suitable.

A method must be chosen to fit the

size and needs of the hospital using it, from economic,
utility, and personell standpoints.

The vacuum sub-

limation procedures, require special and relatively
expensive apparatus and trained personell.

Other methods

described in the text are cheaper, simpler, require little
trained personell attention, and have the added factor
of low operating cost.

They have the disadvantage of

a less desirable end product in most instances.
The administration of blood plasma is a relatively
simple procedure, and it has been definitely proven
that there is no need for typing and cross-matching as
in the case of whole blood.

Obviously this may largely

do away with the problem of blood incompatability, and
open up an entirely new field of endeavor in both civilian
and military medicine.
In the treatment of traumatic shock, with or without
hemorrhage, and in burns, the value of plasma transfusion
has been demonstrated beyond question.

There appears to

be some question as to the optimal concentration for use
and the relative value of plasma and serum in these conditions.

The fact that some disagreement and confusion

ex ists concerning these details, should however, in no
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way detract from the fundamental value of this type
of therapy • . It appears that the normal plasma , instead
of the concentrated form, is more efficient in the prophylactic or therapeutic management of the peripheral
circulatory failure in shock.

The exact amount needed

must be individualized to the patient , the clinician
being guided by the rise in the volume of circulating
blood, pulse, blood pressure , and blood concentration
readings.

The formula of Elkinton, Wolff and Lee ap-

pears to provide an accurate method for the estimation
of the amount of blood plasma needed in cases of shock.
Plasma protein or serum protein transfusions are
to be recommended in hypoproteinemia, rather than whole
blood for the following reasons: (a) they have a greater
effect in restoring the plasma protein level to normal,
{b) they are more effective in increasing, and maintaining an increase, in the circulating plasma volume, (c)
greater effect in initiating diuresis in such states
associated with edema by raising the osmotic pressure
of the plasma, thereby raising the osmotic pressure of
the plasma. volume, and (d) a more utilizable source of
energy in the states of undernutrition.

In the hypopro-

teinemic state, dependent upon inade quate protein intake,
the therapeutic implication seems to be an increase in
the dietary protein.

When this aim cannot be accomplished
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it is justifyable to employ plasma transfusions.

The

same recommendation applies to the therapy of hypoproteinemic states due to excessive protein loss, with the
exception of burns.

In the latter instance shock is

largely dependent upon plasma loss, and plasma or serum
transfusions become an emergency and life saving measure.

In patients with hypoproteinemia associated with a nephrotic state, plasma or serum transfusions, especially in
the concentrated form, appear to be, at least well founded, but perhaps not so uniformly successful clinically as
in other states.

Other miscellaneous conditions have been

mentioned in which blood plasma transfusions have been
of definite value or proven therapeutic aid.
No uniform plan of treatment can be outlined which
would be equally effective for all groups of patients.
Rather, the physiologic needs and the pathological handicaps of each individual patient have to be considered and
evaluated, and the treatment employed regulated accordingly.
A brief discussion of some of the newer substitutes
for whole blood have been mentioned.

Their clinical usage

must await further experimental and clinical study.
The military aspect of plasma has been outlined in
order to supply the reader with the latest available information as to how the role of plasma is serving in our
Armed Forces in the present National Emergency.
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There is

is nop doubt in the mind of the writer that a
brilliant part is to be played in this war by
, blood plasma, and countless thousands of lives
saved, that would otherwise be lost.

out of the

cruel necessities of war has come at least one
blessing--the life saving transfusion of blood
plasma from a healthy donor, to a wounded soldier,
sailor, or civilian thousands of miles away.

It

represents a tremendous forward step in the advancement ·of medical science.
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